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Abstract
The purpose of this ecological quantitative study was to examine the predictors of health
systems building blocks and their interactions in improving access and uptake of
immunizations in nine sub-Saharan African countries. Immunization rates in this region
remain lower than global targets leading to preventable diseases and mortality. Using the
systems approach, the study examined the relationships among five independent
variables: quality of service delivery, governance, vaccine supply, health financing,
socioeconomic factors and the dependent variable, access to immunizations. Datasets
from the WHO and UNICEF were used. Analysis included a series of descriptive
statistics, logistic and linear regression, and correlations. The logistic regression analysis
showed a predictive relationship between the quality of service delivery, governance and
access to immunizations. There was a significant association between immunization and
the presence of a national reporting system for adverse events following immunizations
(OR = 21.630, 95% CI 2.37, 201.040, p < 0.001). A larger Overseas Development
Assistance, calculated as a percentage of gross national income, was associated with a
higher rate of vaccination (p<0.05). Similarly, a higher per capita income and higher
percentage of government funding for vaccination was associated with better vaccination
rates (p<0.001 and p<0.001 respectively). There was also a significant relationship
between the number of doctors in an area and BCG coverage (r= 0.928, p< 0.001) and the
number of doctors in an area and DPT1 coverage (r = 0.892, p< 0.001). The positive
social change implications of this study include how access to immunizations can be
improved using the systems approach focusing on these health systems building blocks.
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Section 1: Foundation of Study and Literature Review
Introduction to Study
Immunizations are life-saving and one of the cornerstones of Universal Health Coverage
and modern medicine. They are effective at preventing common diseases and diseases that had
once been controlled or eradicated, but are now coming back. Diseases like cervical cancer, the
second leading cause of death among women in sub-Saharan Africa (SSA) is now preventable,
so are measles, diarrheal diseases, flu, typhoid, pneumonia which kills so many children and TB
(Black & Richmond, 2018). Other diseases that can be prevented with immunizations include
tetanus, typhoid, whooping cough, influenza and chicken pox (WHO, 2018). Success has been
seen with polio which has almost been eradicated globally except a few isolated cases being
reported. Despite this success, approximately 31 million children under the age of 5 years in subSaharan Africa, are reported to suffer from diseases that are preventable through vaccinations
with more than 500,000 dying due to lack of access to these public goods (WHO, 2019).
Vaccinations against preventable diseases (VPDs) are an effective intervention in
preventing and slowing down existential public health threats like antimicrobial resistance
(AMR), which is a global threat responsible for 700,000 deaths a year globally and projected to
increase to 10 million deaths a year by 2050, a loss of 2-3.5% in GDP and 100 trillion USD by
2050 if nothing is done (WHO, 2019). Immunizations prevent a lot of VPDs which inevitably
reduces the need for antibiotics and the selection pressure. While progress has been made
globally in increasing immunizations, a recent study showed that 19.9 million (15%) of annual
birth cohort of 132 million people, were reported not to be vaccinated or under-vaccinated, 10
million, of which are in sub-Saharan African countries (Madhi & Rees, 2018; WHO (2019).
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The global goals on immunizations are unlikely to be achieved in low- and middleincome countries (LMICs) where targets have not been reached. Among the leading causes of
low uptake of immunizations are health system related factors, such as lack of access to
vaccines, financial and human resources, poor or weak governance structures, lack of and weak
health information systems and poor quality delivery of services. Others are multifaceted
including cultural, social, economic, structural and religious factors. Despite interventions such
as the Expanded Programs on Immunizations (EPIs) aimed at increasing immunizations in most
sub-Saharan Africa, like other LIMCs, low immunization rates have been recorded resulting in
preventable morbidities and increased loss of human life that could have been avoided.
Since vaccinations occur in health systems, they often are an existential systems issue and
understanding health systems would provide the necessary information and knowledge that can
contribute to increasing immunization rates. Health systems are made up of building blocks and
understanding these building blocks, their predictors, and their association with immunizations is
critical in addressing todays challenges. Health systems building blocks as defined by WHO can
lead to sustainable access and increased uptake, averting many morbidities and preventable
deaths. But this would only happen by understanding predictors of these building blocks, how
they interact with each other in the system, how they can be strengthened and identifying areas
where more investments can be directed to effectively strengthen the health system and allow for
better decision making.
There are few or no studies l came across that have looked at predictors of immunizations
in LMICs with respect to the health systems approach, focusing on health building blocks and
how they affect vaccination/ immunization rates in sub-Saharan African countries and other
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LMICs. There are studies that have looked at gaps in immunizations broadly and promoted
various interventions, however few or no studies have looked at the systems approach in
addressing access to immunizations. Some studies have looked at components of the health
system but not holistically and how they interact and how their relationships can be maximized.
Larahira (2015) reviewed articles and India’s Universal Immunization Program (UIP) to show
that strong health systems working in unison could deliver more immunizations to populations.
Kamadjeu (2018) looked at the future of immunization programs in Africa by reviewing
the Expanded Program on Immunization (EPI), which most countries use, making observations
that the success of immunization programs are dependent on strong delivery health systems
components both structural and financial. Nnorom (2017) studied the predictors to access to
maternal medicines using the health systems approach and examining the building blocks and
their predictors. This study though was limited to maternal medicines and mostly solid products.
Vaccine’s, however, are special commodities whose supply chain is different particularly
maintaining the cold chain patency and are mainly administered to children. This is more
important for new vaccines that might require special conditions for transportation and storage.
This study focused on examining the health systems building blocks predictors and their
interactions in increasing access and uptake of immunizations addressing the current gaps in
knowledge in sub-Saharan African countries. The 2020 global goals for immunizations in
LMICs have not been achieved as immunization rates remain at an average of 70% in most
LMICs. If the rates of immunizations remain where they are at an average of 70% in most
LMICs, it is unlikely that the 2030 goals will be achieved. The 2030 vaccination goals include
targets such as reducing morbidity and mortality of vaccine preventable diseases and ensuring
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sustainable access to all (WHO, 2020). For example, a low uptake of pneumococcal and flu
vaccines may lead to many respiratory infections, complications and death among diabetic
patients (Almusalam, Ghorab, & Alanezi, 2019). Since immunizations are provided through
health systems, understanding health systems building blocks thus becomes critical in addressing
current access issues to immunization.
Sub-Saharan African countries made commitments through various global and regional
commitments. One of the major commitments is the Addis Declaration of 2016 intended to
expand immunizations in Africa to reach everyone who needs them by committing to 10
commitments addressing political, technical, financial and investments (WHO, 2020). This is in
addition to the Global Vaccination Plan (GVAP) of 2012 endorsed by WHO member states,
whose focus is to present VPDs by 2020 by focusing on equitable access for all (WHO, 2020).
Knowledge from this study will allow and empower policy makers, immunization
program managers to effectively design evidence-based programs and implement interventions
that will accelerate vaccination goals. This will support implementation research that has been
lacking in most developing countries by providing evidence-based solutions. It will also help
policy makers identify where to focus more investments in the value chain with many competing
priorities including challenges of low funding to increase access to immunizations and their
uptake.
Problem Statement
Immunizations play a major role in preventing many common diseases including
emerging and re-emerging diseases that claim millions of lives each year. The effectiveness of
vaccinations can be seen through WHOs report, which reported 10 million lives saved between
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2010 and 2015 globally because of vaccines (WHO, 2018). Vaccines for diarrhea such as
Rotavirus prevent more hospitalizations and deaths from diarrhea a leading cause of death in
children under 5- years old (Takahashi, Metcalf, Ferrari, Tatem & Lessler, 2017). Another
example is the HPV vaccine for cervical cancer which has been found to be around 95%
effective in reducing cervical cancer (Black & Richmond, 2018). High efficacies of vaccination
have also been shown for rotavirus, measles, pneumonias, polio and typhoid.
However, immunization rates in sub-Saharan Africa remain low with 31 million children
under the age of 5- suffering from vaccine preventable illnesses and more than half dying from
lack of access to immunizations (WHO, 2019). Diseases such as measles which are preventable
through immunizations have a high fatality rate for those who have not received the vaccine and
contract it. While rates of immunizations are high in developed countries who have developed
health systems, the overall immunization rates in the African region remain below the expected
targets, ranging from 57% in 2000 to 76% in 2015 (Mihigo, Okeibunor, Anya, Mkanda &
Zawaira, 2017). Eight (8) countries were under 50% for DTP vaccinations, Chad, Central Africa
Republic, Equatorial Guinea, Nigeria, South Sudan and Somalia (Ablack & Richmond, 2018).
This is concerning with the high burden of infectious diseases and non-communicable diseases in
sub-Saharan African countries.
In 2014, 114,900 deaths of children occurred globally of which 63% (73,914) occurred in
Africa, most of these deaths could have been avoided with vaccinations (Brownwright, Dodson
& van Panhuis, 2017). Immunizations are one of the most successful interventions in public
health. Unfortunately gaps still exist in in many countries with the average of immunizations
being around 70% (Mihigo, Okeibunor, Anya., Mkanda, & Zawaira, 2017). Some examples
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show gaps especially in the indicator vaccine DPT as substantial gaps are seen between the first
dose of DTP and the following doses, attributed to lack of access (ScienceDaily, 2019).
Global goals such as sustainable development goals (SDGs), reducing vaccine
preventable morbidities and mortality, addressing antimicrobial resistance (AMR) and attainment
of Universal Health Coverage (UHC), are unlikely to be achieved in sub-Saharan Africa due to
many reasons and factors that include health systems related factors (McLeod, 2019). Health
system related factors such as lack of vaccines, weak governance and human resources, have a
major effect on access to immunization and often damage many immunization programs in
Africa (Mihigo, Okeibunor, Anya., Mkanda, & Zawaira (2017).
In order to reach vulnerable populations, increase access to vaccinations, strong effective
health systems are key. WHO defines a health system as having 6 building blocks – service
delivery, governance, health information systems, financing, medical products and human
resources (WHO, 2018). When these are effectively working and maximized, they lead to
improved health outcomes, responsiveness, reduction in healthcare related costs, social and
financial risk protection and improved efficiency through improved coverage, quality and safety
(Lazarus & France, 2014). They also contribute to the rise and spread of antimicrobial resistance
by reducing the selection pressure.
Access to vaccines improves health and maximizes health outcomes, it results in healthy
children, health communities and prosperous nations. In order to increase immunizations in SSA
and reduce preventable deaths understanding predictors of key building blocks, how they work
and complement each other and where in the value chain interventions can best be made with a
higher impact is necessary. Without increasing immunization rates, set targets and goals, will not
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be attained leading to morbidities and mortalities and affecting the economic wellbeing of
countries.
This study could contribute to better understanding of the relationships between building
blocks, their predictors and vaccinations and contribute to policies at country and regional level
that would lead to improved access to immunizations resulting in the positive health outcomes.
Purpose of the Study
The purpose of this ecological quantitative study was to look at how health systems
blocks - service delivery, human resources, health information systems, financing and medical
products – vaccines and other medical products and governance affect access to immunization in
9- sub-Saharan African (SSA) countries. These countries fall in the categories of being Low- and
Middle- Income Countries. The predictors and relationships between the building blocks and
access to immunizations were examined and whether certain building blocks as defined by WHO
in the health systems approach and definition that should be emphasized more with more
strategic investments given to them than others? With most SSA countries challenged with
financial and human resources and other competing priorities, African countries need to
prioritize resource investment into health system blocks that will increase access and uptake of
immunizations to prevent, preventable morbidities and mortalities, these however should be
evidence-based.
Research Question(s) and Hypotheses
The study had 5- research questions with corresponding hypotheses:
1. Is there a significant association between the quality of service delivery and access to
immunizations in nine sub-Saharan African countries?

8
H10: There is no significant association between the quality of service delivery and
access to immunizations in nine sub-Saharan African countries.
H1A: There is a significant association between the quality of service delivery and access
to immunizations in nine sub-Saharan African countries.
2. Is there a significant association between governance and access to immunizations in nine
sub-Saharan African countries?
H20: There is no significant association between governance and access to
immunizations.
H2A: There is a significant association between governance and access to immunizations.
3. Is there a significant association between vaccine supply and access to immunizations?
H30: There is no significant association between vaccine supply and access to
immunizations.
H3A: There is significant association between vaccine supply and access to
immunizations.
4. Is there a significant association between health financing and access to immunizations in
nine sub-Saharan African countries?
H40: There is no significant association between health financing and access to
immunization in nine sub-Saharan African countries.
H4A: There is a significant association between health financing and access to
immunization in nine sub-Saharan African countries.
5. Is there significant association between socioeconomic factors and access to
immunizations in nine sub-Saharan African countries?
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H50: There is no significant association between different socioeconomic factors and
access to immunizations in nine sub-Saharan African countries.
H5A: There is a significant association between socioeconomic factors and access to
immunizations in nine sub-Saharan African countries
Theoretical Foundation of Study
Choice of Theory. This study used the systems theoretical framework as its foundation.
This is a theory that posits that within a system there are small units or variables that are
interconnected, interact and work together to get the desired outcome (McCovery & Matusitz,
2014). It acknowledges the complexities involved to successfully deliver services. The systems
approach has found its use in studying health models and to further explore barriers to system
changes such as human behavior (Steenrod, 2014). The systems theory approach found its
beginnings in the 1940’s through Ludwig von Bertalanffy, who described it as a science of
wholeness (Mutale, 2016). He expressed and espoused that systems do not consist of parts that
are autonomous working independently or in isolation, but that they are interconnected
functioning as one unit, as a whole to achieve the desired end (Anderson, 2016). Thus, though
the health system has several building blocks they need to function as one with the different
building blocks operating in a cohesive way.
Mutale et al (2016) used the systems thinking in evaluating a program, Better Health
Outcome through Mentorship and Assessment (BHOMA), looking at interactions, intended and
unintended consequences of different system blocks in Zambia. Bielecki & Stocki (2010)
observed that several national health systems were failing because of they looked at subsystems
to be autonomous and how working as a whole. Lee, Mueller & Tilchin (2017) used the systems
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theory to understand vaccine decision making by looking at the relationships of biological,
clinical, operational, social and economic factors.
Using the systems theory in this study, interactions of health systems, building blocks
where explored and examined in relation to access to immunizations: health information, service
delivery, governance, finance, medical supplies (vaccines) and human resources. Using the
health systems approach, will lead to a deeper understanding of how system components behave
and provide insights in the design and selection of appropriate interventions (WHO, 2009).
All the components of the health system are very important to optimization of a health
system. For example, financial resources are essential to procure and distribute vaccines just as
good governance that creates a conducive atmosphere for operations, information systems that
provide timely and accurate data to act upon, availability of vaccines, trained human resources
and knowledgeable leadership that can make decisions addressing access issues and smart
investments in health systems building blocks. Policy and programs decisions made are based on
the information available, this information has to be accurate and reliable to promote sustainable
access, inaccurate information or data would contribute to the unmet needs (Iyer, Chukwuma,
Mugunga, C., Manzi, Ndayizigiye & Anand, 2018).
Having trained human resources leads to increased efficiencies and effectiveness in
decision making and health service delivery for example training in supply chain functions such
as selection, forecasting, quantification and delivery of immunizations (Prosser et al, 2017).
Additionally, certain sociodemographic and economic index factors affect how people access
health systems and comply to immunizations such as the level of education of mothers, poverty
head count and human development index, costs of immunizations including religious factors.
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Some of these factors were assessed for any association to immunization access. Unfortunately,
the dataset used did not have data on information technology however, this was reviewed from
secondary data though not discussed extensively.
The Rationale for the Choice of Framework
Firstly, access to medicines is one of the major challenges in LMICs, contributing to
more morbidity and mortality with many factors attributed to it. Access to immunization is
particularly challenging as it involves different components and many complex factors that
include procurement functions such as selection, forecasting, procurement, distribution,
administration and finances among others. Immunizations are administered in the context of
health systems, which calls for better understanding of the architecture of health systems and
predictors. Understanding these would help policy makers and program managers maximize
intervention for better outcomes. Using the systems approach is an effective way of exploring the
different elements or health systems building blocks, how they interact and reveals where
strengthening should occur to improve access to immunizations to meet national and global
targets.
Secondly, provision of healthcare and services such as immunization relies on complex
factors at play working in unison. It requires a broader perspective view which the systems
framework approach provides. Understanding these complex factors and their interplay is critical
in the realization of the maximum benefits at the same time strengthening health systems. The
health systems theoretical provides this level of understanding. Knowledge from using this
approach can be used for the other health commodities.
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Thirdly is that the health systems approach has been successfully used to improve access
to newborn immunizations in 6- states in India as an implementation strategy(Gera et al, 2019).
Low vaccination uptake was related to challenges in stewardship, poor service delivery, stockouts and human resources. Using the systems approach they developed intervention strategies
that led to improvement in vaccination of newborns from 55% - 88% in their programs (Gera &
et al, 2019). This shows that the systems approach can be used to explore and understand
predictors of immunizations to guide developing interventions to increase immunizations.
Logical Connection
Mutale et al (2016) used the systems thinking theory to strengthen the health system
riddled with many barriers to increase demand and access to healthcare services, by evaluating
stages of a complex program. They sought to take a broader look and analysis, rather than a
narrow vertical approach. In doing so they used the systems building blocks to show the
interactions between them and determine the cause and effect factors. Largeron, Lévy, Wasem,
& Bresse, (2015) noted that immunizations are key to strengthening health systems by making
contributions to building blocks such as making finances available, human resources and
products, also by reducing costs associated with them through diseases in their study.
Gera et al (2019) used the health systems approach as an implementation strategy aimed
at increasing vaccination rates at birth in 6- states in India. They examined the various building
blocks and bottlenecks to immunizations at birth.
Building on these previous studies and taking a holistic approach which was ideal for this
study, l used the systems theoretical framework, to examine relationships between the building
blocks and access to immunization and their determinants. Since immunizations occur in health
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systems this theoretical framework is ideal to provide insight into factors that lowers
immunization rates and provide points in the value chain of immunization to focus for a high
value in return on investment. This approach is useful in explaining the cause and effect
relationship and how interconnected the building blocks are their predictors.
Thus, understanding the predictors of immunizations by examining the building blocks
and their roles and how they interact, will allow us to further understand where to intervene to
maximize returns as evidenced by increase in immunizations. There is a cause and effect
relationship and a high degree of dependency and interconnectedness building the health systems
building blocks. Provision of vaccines to untrained staff would not support access to
immunizations at all, just like poor forecasting or lack of funds to ensure availability of vaccines
when patients need them. However, understanding the gaps, the influences, characteristics and
behaviors would lead to increased access and uptake of immunizations.
Nature of the Study
An ecological quantitative study method was used for this doctoral study using country
level data from 9- sub-Saharan African countries. Secondary data analysis was done using
secondary datasets from WHO and UNICEF. Quantitative methods are often used to look at
relationships among variables using statistical analysis (CIRT, 2019). The study looked at the
relationship between the dependent and independent variables.
The independent variables used were the 6- building blocks of a health system as defined
by the WHO: human resources, service delivery, medical products, health information, finance,
governance (WHO, 2019). In addition, a select sociodemographic factors where considered in
the study. The dependent variable was access to immunization.
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Literature Search Strategy
Search Strategy
The literature reviewed for this study included peer reviewed articles from the following
academic databases, CINAHL Plus with Full Text, EBSCOhost, NCBI, ProQuest Health, the
Walden Library, ProQuest Central, SAGE Journals, MEDLINE Full Text and PubMED. Other
databases used where ResearchNow, InfoSci journals, Taylor Francis Online, BMJ, Lancet,
google scholar, GAVI, and Science Direct. Additional databases included the WHO, UNICEF,
CDC, CIA, DHIS2 for 8- sub-Saharan African countries. Literature search done was from 2010
to 2020.
Search terms
The following search terms where used for this study, health systems, health systems
strengthening, vaccinations, immunizations, sub-Saharan Africa, access to medicines, access to
vaccines, vaccines and vaccine coverage, pharmaceuticals and National Essential Medicines List.
Other terms included names of vaccines BCG, DPT1, DPT3, OPV3, HBV3, HIB and Measles
included in the study.
Scope of Literature Review
Literature reviewed for this study included peer reviewed articles from scientific journals
including systematic reviews, meta-analysis, reports from organizations involved in
immunizations such as GAVI, UNICEF, WHO including country reports. Others included
USAID articles, African Union, Africa CDC and regional economic groups.
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Literature Related to Key Variables and or Concepts
There is paucity of data for immunizations in sub-Saharan Africa, which paused
challenges, however there is enough evidence and statistics that show that rates of immunizations
in sub-Saharan Africa are far behind many global set targets. Data is often missing in country
datasets and some districts are missed out. There is still enough data for analysis. In 2017, 19.9
million children did not receive immunizations with the larger percentage of these children being
in sub-Saharan African countries. DTP3 coverage for example, remained at 72% in African
countries for almost 10 years despite the increase in infant births, below the Global Vaccine
Action Plan (GVAP) of 90% or more target (WHO, 2019). WHO (2019) reported that 20.8
million people under 1 year did not receive a single dose of measles vaccine in 2017. Access to
vaccines remains to be a challenge in this region.
Global statistics on global and sub-Saharan Africa statistics
There is paucity of data in most LMICs compared to developed countries
regarding access to immunizations and immunization rates, which has improved over the last few
years. Data is often incomplete for certain variables and often incomplete. Despite this
challenge, there is enough evidence and data that show that rates of immunizations in subSaharan Africa are far behind many global set targets. In 2017, for example, 19.9 million
children did not receive immunizations with the larger percentage being in sub-Saharan African
countries (WHO, 2019). Diptheria, Tetanus and Pertussis 3rd vaccine (DTP3) coverage, remained
at 72% in African countries for almost 10 years despite the increase in infant births below the
Global Vaccine Action Plan (GVAP) target of 90% or more (WHO, 2019). 20,8 million people
under 1 year did not receive a single dose of measles vaccine the same year, 2017 (WHO, 2019).
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Globally there has been an improvement in reducing mortality rates for children with the
UN, reporting a decline of 58% since 1990 and a remarkable drop in the number of deaths of
children under the age of 5 years from 12.6 million in 1990 to 5.4 million in 2017 (UN, 2019).
Despite this progress the report noted that still most children under the age of 5 years die from
preventable diseases such as pneumonia, diarrhea, and neonatal sepsis, where effective
interventions like immunizations would have prevented the deaths (UN, 2019). In the US another
key constituent who die from vaccine preventable diseases are the elderly, contributing 50,000
to 90,000 deaths a year (IDPV, 2020).
Through the use of vaccines some diseases such as polio and smallpox have been
eradicated. Major progress has equally been made in eliminating maternal and neonatal tetanus, a
high child killer with a fatality rate of 70 to 100%, globally, with only 13 countries remaining
since 2019 (UNICEF, 2019). This shows how effective immunizations are in preventing
diseases.
The case for immunizations: Immunizations are the cornerstone of modern medicine
and one of the most effective public health interventions in modern history. Through
immunizations, many diseases, disabilities and mortality can be prevented. Examples of these
diseases with a high toll on morbidity and mortality, include yellow fever, diptheria, tetanus,
mumps, hepatitis B, pneumococcal infections, pertussis, polio and haemophilus influenza type B
infections (UNICEF, 2019). Other diseases are TB, hepatitis A, rotavirus rabies and yellow
fever (UNICEF, 2020).
The impact and success of immunizations can be seen from mortalities they prevent and
the decline that has been seen for some highly infectious diseases. Immunizations saves lives and

17
have contributed in the decline of under 5 years mortality rate by 24% from 2010 to 2017 and
prevent 2 – 3 million deaths every year (IHME, 2020, WHO, 2020). Measles a highly contagious
infectious disease and killer for children declined by 80% within a 17-year period from 2000 to
2017 averting 21.1 million deaths due to increase in immunization coverage (UNICEF, 2019).
sub-Saharan Africa has the highest burden of infectious diseases, home of half of the world’s
poorest and deals with a triple burden of HIV and AIDS, TB and malaria. Most of these
infectious diseases can be prevented through immunizations. However, gaps still exists and
understanding them through a health systems lens would enable this region to enjoy the success
that mots western countries enjoy. DTP3 is a vaccination that is used as good indicator for
immunization programs, in 2018, 19.4 million infants globally did not receive DTP3 vaccine,
with 60% of those coming from LMICs including sub-Saharan African countries (WHO, 2020).
Vaccinations also contribute to reduction in the spread of infections in communities
where more people have been vaccinated and have developed herd immunity. Other benefits of
immunizations are that they are a very cost effective intervention, saving millions of dollars that
can be invested in other heath programs and directly in health systems strengthening. For every
dollar spent on measles vaccinations in 94- LMICs, there is a return on investment of USD 58,
this averts disabilities including death but also cuts healthcare associated costs (Ozawa et al,
2016).
Immunizations also lead to prosperity in countries and is a good economic indicator.
They lead to healthier and prosperous communities as fewer people get sick, children do not miss
school, parents do not miss work, healthcare expenditures are low, the stress on health systems is
reduced allowing saving of funds that can be directed health systems strengthening and other
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country progressive agendas. Immunizations will prevent 24 million people being pushed in
extreme poverty by 2030 (Chang et al, 2018).
Immunizations also are a sensitive intervention for a major public health crisis of
emerging and re-emerging infections including antimicrobial resistance. They reduce the demand
for the use of antibiotics and emergency of resistant pathogens. Ramanan et al (2018) estimate
that antibiotic use for PCV can be reduced by 47% in pneumonia patients, an equivalent of 11.4
million antibiotic days, which is very significant.
Immunizations also contribute to global goals and key to the attainment of SDG 3, whose
goal is to ensure healthy lives for all and promote well-being and affects some SDGs directly and
others indirectly (WHO, 2020). Sub-Saharan African countries made commitments to global
goals such as the SDGs, International Health Regulations (IHR) and the Immunization Agenda
2030. The Immunization Agenda 2030 theme is that of leaving no one behind by committing to
ensuring that everyone, everywhere has access to immunization and attain the goals of health
(WHO, 2020) The impact will be equitable access to vaccines for all, attainment of the highest
level of health through strong immunization in primary health care and contributing to the
reduction in morbidity and mortality from preventable diseases (WHO, 2020).
Vaccine Supply: Access to life-saving vaccines is still one of the major challenges for a
number of countries that include sub-Saharan African countries and most fragile nations. This
largely depends on vaccine supply factors, that include supply chain. Popova & Palacios (2015)
noted that children under the age of 5, are15 times more likely to die in sub-Saharan Africa
compared to the same age group in developed countries due to lack of access to life-saving
vaccines. UNICEF (2019) reported that approximately 1.5 million children died from
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preventable infectious diseases, citing lack of access to vaccines as one of the major factors, 50%
of those deaths could have been prevented. Weak immunization supply chain systems impede
access to immunizations in sub-Saharan Africa and remains one of the major barriers (Vouking
et al, 2019).
Financing and cost of vaccines – Lack of affordability of vaccines due to lack of
funding, is another issue some countries have to deal with that lead to lower uptake of
immunizations. This will become a major challenge as countries graduate from the Global
Alliance for Vaccines and Immunization (GAVI) and are expected to take up most of the costs of
procurement and supply chain. Ethiopia for example gets 100 million USD from donors of the
150 million USD it spends every year on vaccines procurement, once it graduates it will have to
finance the entire 150 million USD, which will be an onerous task (WHO, 2019).
Health information systems: Information about vaccines and immunization is critical
for developing and managing immunization programs. This information feeds into the
procurement systems guiding forecasting, procurement and distribution of vaccines in a country.
WHO (2020) determines 4- essential functions of health information systems as generation of
data, collating and compilation, analysis and communicating to key policy and decision makers
for decision making (WHO, 2020). Health systems need to ensure adequate steady supplies of
vaccines to avoid stockouts and vaccines expiring on the shelfs. Unfortunately, in most subSaharan African countries, health information keeping is still paper-based, making it very
difficult for transmission of data on time and analysis to allow for evidence-based decision
making. Electronic information systems have been found to be improve immunization coverage.
They have many benefits that include accurate record keeping, allows individuals to be followed
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up easily, helps with immunization surveillance, tracking of defaulters and support clinical
decision making (Danovaro-Holliday et al, 2019).
Governance: Immunization programs are run by governments. They are critical in
setting country priorities, developing policies, providing technical and financial resources and
strengthening health systems. Other functions include creating enabling environments that
promote and support immunizations, regulation frameworks, developing and dissemination of
information and accountability (WHO, 2019). Governance and leadership are also key in
performing procurement and supply chain activities for vaccines in most LMICs. Leadership and
governance functions that determines access to immunizations include .
Human Resources: Having adequate human resources that are trained is key for
achieving immunization goals. Staff should have proficiencies in data management in addition to
documenting, analyzing and feeding data into health systems and channels that can us it is
important (Nicol, Turawa & Bonsu, 2019). Unfortunately, most health facilities in LMICs are
under-staffed and most staff do not have adequate training on vaccines, and lack skills in
handling immunization data and how to efficiently use it in healthcare delivery (Nicol, Turawa &
Bonsu, 2019). This is often expressed in poor quality and incomplete data that makes planning,
monitoring and evaluating interventions extremely challenging. Human resources are thus a key
component of a health system.
Studies Related to Key Constructs and Methods
Literature on determinants of access
One of the definitions of Access to medicines (ATM) looks at it as having 4- dimensions,
accessibility, availability, affordability and acceptability of medicines (Costa & e tal, 2017).
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Improving access to medicines requires an understanding and appreciation of these 4 key
elements. Management Sciences for Health (MSH) promoted this model showing the interactions
and relationships including the strategies to include access through education, strengthening
management, instituting regulations and economic such as using procurement strategies as
pooled procurement to leverage on economies of scale and getting better pricing (MSH/CPM,
2011).

Figure 1
Access Framework

Note. From CPM/MSH 2011
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Accessibility refers to ensuing that the medicines are located where patients can get
them, availability refers to the trait that medicines are available in the right quantities and when
they are needed, affordability means that medicines are affordable to patients and not prohibitive
in pricing while acceptability refers to medicines being able to be used, having characteristics
that do not hinder patients using them (WHO, 2020). Bridgeli et al (2003) discussed the ATM
framework by incorporating the components of supply and demand and the dynamic relationship
between the two.
Table 1
Domains and determinants covered in existing frameworks of ATM
ATM Framework

Domains

WHO-MSH 2000
(Centre for
Pharmaceutical
Management 2003

Availability

WHO 2004c

Specific
Determinants
Medicines’ supply—
type and quantity
Medicines’
demand—type and
quantity

Affordability

Prices of drug
products and services
User’s income and
ability to pay

Acceptability

Characteristics of
products and services
User’s attitudes,
expectations of
products and services

Accessibility

Medicines’ supply
location
User location

Rational use

Rational therapeutic
choices

Cross-cutting
Determinants
Quality of products
and services

Quality of medicines
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Improved medicines’
use by consumers
Affordable prices

Medicines’ pricing
policies

Sustainable
Financing

Resource
mobilization
Pooling
Reduction of out-ofpocket expenditure

Reliable health and
supply systems

Frost and Reich
(2010).

Availability

Affordability

Medicines
procurement and
supply
Regulation
Human resources
Manufacturing
Forecasting
Procurement
Distribution
Delivery
Government
affordability
Non-governmental
agency affordability
End-user
affordability

Architecture:
organization
relationships at
national and
international level

Adoption
Global adoption
National adoption
Provider adoption
End-user adoption
and appropriate use
Note. From Bigdelo et al., (2013)
The UN define access as the continuous availability and affordability of medicines at
health facilities including drug outlets that can be accessed within one hours walk from patient’s
residences to a health service facility (UN, 2019). Emphasizing similar characteristics as MSH.
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The 4 As, availability, affordability, accessibility and acceptability are systems characteristics
and one can look at the predictors of each and how they affect overall access to immunizations.
Philips, Dieleman, Lim & Shearer (2017) proposed a framework for determinants to
vaccine utilization as intent to vaccinate, facility readiness and community access. Intent to
vaccinate looks at the demand side for vaccines while facility readiness looks at the supply side
including supply chain factors and community access, response of communities for uptake or
not. The study however did not look at the predictors to access for these elements. One of the key
elements in raising the demand for immunizations is having a strong and efficient health system
that utilizes primary health care and outreach programs in the community that raise awareness.
Financing: One of the major challenges to access is financing both at the individual and
national level. When vaccines are expensive patients cannot afford them limiting access and
countries do not procure to distribute in the country. Inadequate financing and budgeting thus
affect’s availability and affordability of vaccines. Most LMICs do not use their own resources to
procure vaccines but depend on donor funding. Access to immunization is still a challenge with
many countries progress stalled in the last few years, showing 1 in 5 children not receiving all
vaccines required in LMICs (GAVI, 2020). Ozawa et tal (2016) analyzed the funding gap in their
study for 94- LMICs over 5 a period of 5 years from 2016 – 2020 for full immunization costs.
The result of their study underscored the importance of the need for more financial resources that
would result from multiple stakeholders including governments working together to ensure
comprehensive support of the value chain of immunization programs that includes the
procurement cycle: forecasting, procurement, delivery and administration as they showed a gap
of $7.6 billion (Ozawa et al, 2016). 98% of that of the gap was for routine immunizations,
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running immunization programs is costly and most LMICs cannot meet the costs within their
budgets (Ozawa et al, 2016).
Sociodemographic factors - Other factors include sociodemographic factors such as
level of education of mothers and distance from health facilities. A strong association has been
observed between vaccination rates and maternal level of education, higher vaccination rates are
seen in children with mothers that have higher levels of education (Cao, Zheng Cao, Cui, Duan,
& Xiao (2018). The distance to health facilities and time it takes to the health facility are other
determinants, the further the health facilities are or vaccination sites, the more unlikely that
patients would travel for vaccinations or mothers will take their children (Cao, Zheng, Cao, Duan
& Xia, 2018). The closer the health facilities are to the communities the more likely that high
immunization rates will be observed.
At the industry level, The Access to Medicines Foundation uses 2 models to measure
performance of pharmaceutical companies’ efforts to improve access to medicines and vaccines
and to stimulate them to increase access efforts (ATM, 2029). The indexes used are, Access to
Medicines Index (AMI) and Access to Vaccines Index (AVI). Indicators used to rank companies
include investments in R&D, pricing, donations and licensing, measuring how industries have
performed in each of these areas and giving them a score that is published every year. This
acknowledges that access is not only affected by the demand factors but supply factors.
Indicators that can be used to assess access to immunization using the systems approach
are summarized in the table below with necessary indicators.
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Table 2
Proposed Indicators to be used from WHO/UNICEF Estimates of National Immunization
Coverage(WUENIC) and the Joint Reporting Form (JRF) estimates Adapted from WHO
Variable
Dimension of
system
Finance

Indicators

Service
Delivery

Physicians per 1000 population
Community Health Workers per 1000 population
Health care workers aware or vaccination schedules
Is there a stock-out at national level for BCG
Is there a stock-out at national level for DTP

Medical
products Vaccine
Supply

Health Expenditure (% of GDP)
Govt. Health Expenditure (% of GDP)
Per capita Gross National Income
Official Development Assistance
(% GDP) Received
Percentage of total expenditure on routine immunization financed by
government funds?
Are there line items in the national budget specifically for the purchase of
vaccines used in routine immunizations?
What amount of government funds are spent on vaccines?
What is the total expenditure (from all sources) on vaccines used in routine
immunization
Percentage of total expenditure on vaccines financed by government funds
What is the total expenditure (from all sources) on routine immunization?
Percentage of total expenditure on routine immunization financed by
government funds?

Is there a stock-out at national level for BCG, Hep1, Hep2 Hep3 and PCV
If yes, specify duration in months – BCG, Hep1, Hep2 Hep3 and PCV
Main cause for BCG stock-out, Hep1, Hep2 Hep3 and PCV
Is there a stock-out in any district for BCG, Hep1, Hep2 Hep3 and PCV
Was the district level stockout linked to a national one for BCG, Hep1,
Hep2 Hep3 and PCV
Vaccination services interrupted because of lack of vaccine for BCG, Hep1,
Hep2 Hep3 and PCV
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Systems

Number of districts with DTP3 coverage categorized ( <50%, 50-79%, 8089%, > 90%)
% of districts with DTP3 coverage categorized <50%, 50-79%, 80-89%, >
90%, >=95%
% of districts with DTP3 coverage categorized <50%,
Drop-out rate between DTP1 and DTP3 coverage
% of districts with MCV2 coverage <50%, 50-79%, 80-89%, > 90%)
Drop-out rate between MCV1 and MCV2 coverage
Governance
Has the country a Multi-Year Plan (MYP) for immunization?
and
Has the country an annual workplan for immunization activities?
Regulation
% of districts with micro plans including activities to raise immunization
coverage
Has the immunization programme a CMYP supply chain improvement plan?
Is there a national system to monitor adverse events following immunization?
Does the immunization programme have a dedicated immunization supply
chain manager at national level?
Note Proposed variables and indicators
Health systems
Indicators of strong health systems can be evaluated by using both the process and
outcomes indicators. Strong health systems have a higher chance to deliver immunizations,
reduce stockouts, meet national and global targets and lead to reduced morbidity and mortality
and better outcomes. There is also a positive result from immunizations of children and the
elderly that leads to reduced strain on health systems, such as hospitalization, length of hospital
stay, increased costs of diagnostics, human resource demand and treatments and other related
health care costs (Largeron, Levy, Wasem & Bresse, 2019). Strong supply chain systems also
contribute to lower nosocomial infections and antimicrobial resistance that leads to increased
health care costs, morbidity and mortality.
Kamadjeu (2018) looking at the future of immunization programs in Africa reviewed the
Expanded Program on Immunization (EPI) and observed that the success of immunization
programs are coupled with strong delivery health systems components both structural and
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financial. Reaching more people for immunization through the EPN remain the greatest
challenge (Kamadjeu (2018). The strength of a health system can be determined by the
effectiveness of programs like the EPI programs as they cannot be decoupled from the
performance of a health system they operate under (Kamadjeu, 2018). immunization programs
are run by the national government and thus make them as key stakeholders. The EPI program
involves complex processes and elements working together and thus are a good mirror image of
a health system.
Information System
Effective information systems are important for many reasons that include ensuring
accurate documentation, ease of collecting and collating information, analysis of data and
transmission of data to the district provincial and country level. However most Extended
Immunization Programs (EPI) face challenges with data due to poor documentation, collation
and effective utilization of information as they remain paper-based. Namageyo-Funa, Samuel,
Bloland, & Macneil (2018) recommended that moving away from paper-based immunization
records to electronic-based immunization records would lead to increased effectiveness and
efficiencies in immunization programs in African countries. Information on consumption,
utilization and forecasting including procurement would easily be accessible and strengthen
decision making processes. It would also reduce the time that paper-based reporting takes.
Clearly better documentation, sharing and utilization of this data would have a high impact on
access to immunizations. Information transmitted inform many decisions made such as
procurement and supply chain decisions, new improvements interventions, budgetary, education
and staff competencies, policies and standards.
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Yawson & et al (2017) observed several factors in their study, that affected failure to
reach child immunization goals in Nigeria, these included inadequate vaccines, lack of access to
health facilities, gaps in human resources capacity on immunizations and weak health delivery
systems such as information. systems. All the factors identified and stated are components of the
health system as defined by WHO.
Findings from past research
Mihigo, Okeibunor, Anya, Mkanda and Zawaira (2016), looking broadly at the
challenges of immunization in Africa made a number of observations that included the
challenges in logistical capacity of many countries, especially the cold chain needs for new
immunizations and lack of funding. Funding immunization programs remain a major challenge
for most SSA countries. Only a few countries allocate funds in their budgets for vaccine
procurement, a major contributor to frequent stockouts of vaccines resulting in poor access and
reduction of confidence in health systems.
Most African countries depend on funding from GAVI for their immunization programs,
only 5 countries fund immunizations at 100% with more than half of the countries funding less
than 50% and 10 countries funding at <20% (Mihigo, Okeibunor, Anya, Mkanda & Zawaira,
2017). With the disruption to African economies COVID-19 has done, this will even be a major
problem leading to disruptions of many country programs, loss of revenue for countries,
increased costs of healthcare and health outcomes.
Weak laboratory infrastructure and laboratory capacity contributes to the challenges of
identifying causative organisms for certain diseases. This is even more important now when we
have emerging and re-emerging infectious diseases. In Africa most immunization programs
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depend on the laboratory infrastructure for polio eradication, which is now a problem as funding
for polio eradication goes down (Mihigo, Okeibunor, Anya, Mkanda & Zawaira, 2017).
Current supply chain systems are stressed meeting requirements of newer vaccines that
may require special handling and storage on top of the requirements of cold chain and have to
reach communities in the last mile.
Most immunization programs in LMICs are funded by partners, GAVI the vaccine
Alliance being one of them and developmental partners. LMICs require a paradigm shift in
immunization financing as funding channels shrink and some countries graduate into the middle
income category which will remove them from countries supported by GAVI. The funding gap
for African countries between 2016 – 2020 was projected to be $5 billion, this would prove to be
a challenge for most countries due to competing priorities and their response to emerging and
remerging infectious diseases (Mihigo, Okeibunor, Anya, Mkanda and Zawaira, 2016),
Adedokum, Uthman, Adekambi and Wiysonge (2017) used the cross-sectional study and
secondary data to explore and examine factors that lead to incomplete childhood immunizations
by looking at individual, community and state factors in Nigeria. Their findings showed an
alarming high percentage of children had not completed their recommended immunizations, ¾ of
children (76.3%) with major determinants being illiteracy of parents and those who lived in low
socio-economic settings. These settings have weak health systems that could contribute largely
to low immunization rates and most parents are unable to afford user fees.
Nnorom (2017) used secondary data for a cross-sectional study that looked at health
predictors of access to maternal health medicines. She used the health systems approach and
access to misoprostol, oxytocin and magnesium sulfate used for post-partum hemorrhage. Using
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the systems approach her conclusions included the observation of the disproportionate of
distribution of post-partum hemorrhage in LMICs, the need to expand the way certain health
systems components are looked at like finance to include accountability and need for
strengthening the supply chain. Nnorom (2017) also concluded that access to essential maternal
medicines was significantly predicted by the strength of the health system, procurement
practices, distribution and financing.
Cooper, Betsch, Sambala, Mchiza and Wiysonge (2018) did not use the systems approach
in their study but looked at vaccine hesitancy as a threat to achieving vaccination goals and
benefits in African countries. They argued that while many studies have been conducted in highincome countries few studies if any had been done in Africa, more studies needed to be done that
would take into consideration unique factors in the African context and lead to developing
context specific interventions that could increase access and uptake of immunizations (Cooper,
Betsch, Sambala, Mchiza and Wiysonge (2018). A strong health system that meets the needs of
communities needs to be built taking the local situation into context.
Boyce et al, (2019) observed how challenging data for immunizations in African
countries is and proposed to develop and pilot tools that would be used to identify areas with
limited access to immunization services and use that as proxy for immunizations. Data is crucial
to successfully run immunization programs especially accurate data that can be used for correct
forecasting, determining the unmet need, inform procurement and other policies that would
increase access to immunizations. The areas that are the most challenged are rural areas, they
often have unstructured methods to collect data, new tools thus would increase the ease and
strengthen data collection (Boyce et al, 2019).
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The success of immunization programs depend on supply chain in particular – vaccine
delivery proposed Utazi et al (2019). Using DHS data, they mapped predicted coverage at
1X1Km spartial resolution in 5- LMICs and determined under vaccinated areas resulting from
gaps in the delivery systems (Utazi et al, 2019).
Operational Definition of Terms
Access to immunizations: Access to immunization refers to the concept of having
vaccinations available at all times, the right quantities, affordable, acceptable and acceptable
(WHO, 2020). This is measured by rates of immunizations, policies in place to promote
immunizations such as the country having a Multi-Year Plan (MYP) and percent of districts with
coverage of a particular immunization. Access is referred to as the 4 A’s:
Availability: vaccines that are in stock all the time in healthcare facilities.
Affordability: Vaccines that all population members can afford to purchase or access
even when they have to pay user fees.
Accessibility: vaccines that all population can get to with no limitations of distance, time
nor other hindrances.
Acceptability: vaccines that are acceptable in communities in consideration of their
cultural, religious or side effects.
Building blocks of health systems: Health systems building blocks refer to service
delivery, health workforce, information, medical products, vaccines and technologies, financing,
and leadership/governance as defined by WHO (Manyazewal, 2017). The health building blocks
are critical to the delivery of health services and achievement of optimal health outcomes.
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Health system: is a system whose primary purpose is to achieve health, the maximum
status of health possible, promote, restore and maintain health and involves the interaction
between institutions, people and resources (WHO, 2020). Almost all the countries in the world
are committed to the provision of health services to their citizens as one of their fundamental
roles.
Essential medicines: these are medicines that the population cannot afford to not to have
to meet their health needs. These are medicines that should be available all the time and achieve
the 4 elements of access, affordable, accessible, accessible, are available all the time with assured
quality (WHO, 2020). These include vaccines.
Analytic Strategies
The statistical Package for Social Sciences, IBM SPSS Statistics 25 software was used to
perform both descriptive and inferential statistics. Both univariate and multivariate analysis were
performed. Using select variables from the data, Chi square and logistic regression was
performed to show relationships between variables and their statistical significance to answer the
research questions. The p value of 0.05 was used to determine significance..

Assumptions
Assumption 1
The WHO/UNICEF dataset that was used in this study were assumed to be representative
of a country and complete. The methodology and tools used for joint reporting by countries
were reviewed in order to ensure that they were similar across countries so that the data on
immunizations, access, human resources or financing were comparable between countries.
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Assumption 2
The assumption was made that all the data collectors were trained, did due diligence in
collecting data using the same methodology and that the data is truthful.
Assumption 3
My other assumption was that the data submitted to WHO and entered into the system
was complete, verified and accurate and captured information on all the vaccines. Also, that
quality assurance was ensured
Scope and Delimitations
The aim of this study was to examine how health systems building blocks pertaining to
vaccines, affect access to immunization in sub-Saharan African (SSA) countries. This was done
by using the ecological study design. Select variables for each building block most relevant to
the study and where sufficient data was available was selected using the secondary dataset.
What this study did not look at was to determine causation. Cause and effect cannot be
determined by using an ecological study design. One of the characteristics of ecological studies
is based on the intent, the intent is to study relationships at the population level involving
exposure risk and the contextual effects on the population study and not the causal relationships
(Nature, 2020).
This study was based on population data that WHO and UNICEF collect from member
countries using standardized tools for immunizations and indicators they use for measuring
access. This data is collected every year and is dependent on countries self-reporting. Countries
have been taught on data collection.
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Limitations, Challenges, and/or Barriers
The challenges l faced in this study was the lack of availability and insufficiency of some
data on certain immunizations used as proxies. For some countries not all district had reported
immunization data contributing to data insufficiency and completeness. Most LMICs face the
challenge of lack of good data, insufficient and complete data and good repositories. This is
coupled with the lack of electronic reporting systems leaving them dependent on paper-based
information systems. Data on information systems was scant and mostly qualitative in different
data sets.
Using secondary data is a challenge most times due to the fact that the primary reason for
which data was collected may be different from the research question or reason the user of the
data might have. It might also be a challenge to have an adequate sample size that would allow
statistical analysis.
In this study, the percentage of missing data varied from measure to measure. A
minimum of 7.6% missing cases was found in the case of the dependent variable, with a
maximum of 42.4% in the case of the question asking "Is there a stock-out in any district for
Measles?" In the logistic regression analyses conducted, valid sample sizes ranged from a
minimum of 114 to a maximum of 178. With regard to the categorical measures included in this
study, the dependent variable had data points of zero with respect to only six cases (3.3%).
05160 was found to have 31 cases (17.3%) of cases which had data points of zero, with 13198
having 30 cases (21.6%) with entries of one. Next, 13204 had 19 cases (15.0%) with values of
one, with 13249 having 22 cases (19.3%) with values of one. 13246 was found to have 16 cases
(11.8%) with values of one, and with 06167 having 18 cases (10.1%) with values of zero
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The other limitation is that the study did not look at all the immunizations but selected a
few immunizations that all the countries have on their mandatory list which had sufficient data.
The immunizations used as proxies were BCG, DPT1, DPT3, OPV3, HBV3, HIB3 and Yellow
Fever. These provided a good sample for analyzing access to immunizations.
Summary, Significance and Conclusion
The national and global goals on health, promote well-being and enjoyment of health to
the full extent possible. The third- sustainable development goal (SDG), focuses on health and
has indicators that include reduction of mortality rates for infants and mothers by 2030, provision
of universal health coverage including health services, medicines and vaccines (WHO, 2019).
SDG 3- also focuses on the reduction of premature mortality by a third (1/3) from noncommunicable diseases (NCDs). The Immunization Agenda 2030’s vision is to have sustainable
access to vaccines for everyone with the impact goals of reducing vaccine-preventable morbidity
and mortality, and ensuring the highest level of health for everyone by strengthening health
systems including primary health (WHO, 2020). Achieving these immunization goals could
reverse and prevent the high morbidity and mortality in sub-Saharan Africa, a region with the
highest maternal and infant mortality rates, most of which are preventable through
immunizations (Doctor, Nkhana-Salimu & Abdulsalam-Anibilowo, 2018).
Rates of immunizations are a very good indicator and determinant of healthy
communities and economies. It is very unlikely that national goals and global goals on any
economic indicator whether it be on education, energy, employment, disease containment and
creation of healthy communities can be attained without healthy people and health interventions
such as vaccinations. Immunizations are very cost effective with a high return on investment,
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showing high numbers of lives saved, economic savings and reduction in the demand and stress
on health systems. For example, in the US the Heamophilus influenzae type B vaccine has 12
billion USD attributed to indirect costs and 5 billion USD to direct costs, for smallpox the
estimates are at 300 million USD in direct costs yearly while for DTAP, USD 24 is saved for
every USD spent in investment (Rémy, Zöllner, & Heckmann, 2015). Failure for SSA countries
to provide immunizations to the last mile, will result in continued economic loses, weakened
health systems, increased morbidity, increased infant and maternal mortality rates, noncommunicable diseases (NCDs) and failure to achieve global goals such as the Immunization
2030 Agenda and SDGs.
Debilitating diseases such as polio have been eradicated through effective vaccination
programs, failure to continue providing vaccinations could see these diseases coming back.
While there are many factors that contribute to rates of immunization from personal, cultural,
economic, structural, to state of health systems, countries with strong health systems tend to
have higher immunization rates than those with weak health systems. One can attribute
immunizations rates as being a health systems issue as they occur within heath systems.
Lack of immunizations have several secondary impacts apart from preventing diseases,
these include causing severe diseases which lead to hospitalizations, increased hospital stays,
increased costs associated with that, increased secondary infections, that may lead to the use of
expensive antibiotics, increased morbidity, increased costs of treatment and deaths.
Immunizations contribute to strengthened health systems by lowering the stress on them, costs,
reducing utilization of health care and by preventing hospital acquired infections and infections
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that might lead to additional hospital days by 4 – 12 days (Largeron, Lévy, Wasem, & Bresse,
2015). They are a very good preventive intervention to diseases.
While there are studies that have looked at access in terms of solid formulations, there are
very few studies if any l came across, that have looked at vaccines, which are specialized
products with peculiar challenges such as maintaining the cold chain patency from procurement,
transportation, storage to administration and other complex factors including financing.
Immunizations are often administered to healthy people that might delay the urgency of
receiving them.
The study will contribute to social change by generating knowledge and showing the
predictors of building blocks and their association to access of immunizations, show where
countries can focus in strengthening health systems by using the health systems approach and
best leveraging them to increase immunization access in SSA countries. The study could also
inform and influence policies aimed at improving interventions to address the current challenges
of access to vaccines and meeting the unmet needs. Equally through strengthened health system
with improved access, members of the communities will develop more trust in health systems
that might result in increased uptake of vaccinations.
Immunizations are one of the most effective public health interventions. They offer
protection from so many infectious diseases such as polio, malaria, measles, pneumonia,
hepatitis and non-communicable diseases like cervical cancer. Globally 2-3 million deaths are
prevented due to immunizations every year (WHO, 2019). Despite the evidence of success in
immunizations, immunizations rates in sub-Saharan Africa still fall short of global targets.
According to the WHO (2019), the estimates for 2018 show that 19.4 million children less than 1

39
year old did not receive basic vaccines. The average rate of immunization in sub-Saharan Africa
is 72% which unfortunately exposes many in the population to vaccine preventable diseases
(VPDs), (WHO, 2019). Estimates from WHO Africa region, show that 19.4 million infants
globally were unreached for immunizations in 2018 (WHO, 2019).
Lack of access to immunization services and vaccines, is one major reason that has led to
lower immunizations in the region. Increasing access to vaccines would lead to increased access
to vaccines that would prevent vaccine preventable diseases. Vaccine preventable diseases affect
31 million children under 5 years, with over 500,000 dying from lack of access to vaccines every
year, majority of these being in sub-Saharan Africa (WHO, 2020).
Immunizations occur within health systems, through the Expanded Programme on
Immunization (EPI). A health system consist of 6 building blocks as defined by the WHO. These
include finance, service delivery, information, medicines (such as vaccines), health workforce,
and governance (WHO, 2019). Gaining an understanding of the building blocks and their
predictors would lead to targeted interventions that lead to increased access to immunizations.
They would lead to evidence-based decision making, policy development, well-resourced health
system, better forecasting and procurement and improved service delivery. These systems
building blocks need to work in unison and in sync to maximize their effect and achieve the
health outcomes of a health system.
Ensuing equitable access to immunizations has been one of the major global goals. The
UN sustainable development goal number 3 is on health, to ensure heathy lives and on health,
and promoting well-being for all (UN, 2019). Some of the key targets include achieving
equitable access to universal health coverage, health care services and to quality, affordable

40
vaccines and to prevent infant and children under 5 deaths which are preventable through
vaccinations and access to healthcare services (UN, 2019).
The Africa Union realizing the need to increase access to immunizations had the Head of
States sign and endorse the Addis Declaration on immunization whose goal was to ensure
equitable immunization for all children regardless of their economic social circumstances (WHO,
2019). In 2016 African countries committed to the Universal Access to Immunization declaration
and reaffirmed their declaration to achieve immunization rates of 90% by 2020 and committed to
the Regional Strategic Plan for Immunization (RSPI) for Africa that included targets such as
elimination of polio, measles and maternal and neonatal tetanus. (WHO, 2020).
I chose to use the ecological study design for this study, a study design that has been used
and suitable to study populations and not individuals and allows for comparisons between
countries. The study did not look at the cause and effect but the association between the
dependent and independent variables: access to immunizations and health systems building
blocks respectively. The WHO/UNICEF dataset was the primary dataset used for this study.
Section 2: Research Design and Data Collection
Introduction
In this section, an elaborate explanation was provided on the proposed statistical
approach to be employed to study the relationship between the variables of interest. The main
topics that were addressed in this section included the research design and the rationale of
choosing it, the study variables and the methodology. In the methodology segment, detailed
explanations of the target population, sampling and sampling procedures, instruments of measure
and the data analysis plan were provided. The chapter also provides the threats to the internal,
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external, construct and statistical conclusion, and ethical procedures that were used to achieve
validity. The section also includes how data was handled with confidentiality and the IRB
approval process and any ethical considerations.
Research Design and Rationale
This study was an ecological study using secondary data on immunizations in subSaharan African countries. The study examined the predictors of access to immunizations in subSaharan Africa, by looking at the health systems building blocks and their relationships to
access. Setia (2016) defined cross-sectional study design as a type of observational study
whereby the exposure is not altered and the researcher measures outcomes and relationships in
the population. Ecological studies are observational studies where one of the characteristics is
that data is analyzed at the population and not individual level, for example, comparing groups of
people like countries (Neumark, 2017). Relationships are examined by looking at rates and
exposures in the population (Neumark, 2017).
Limitations of ecological studies include the fact that casual relationships are difficult to
derive (David, Geier, Kern, & Geier, 2018). Despite this weakness and that of biases, ecological
studies are widely used in public health for health planning, monitoring and evaluation, they are
less expensive and easier to conduct which my study benefited from (Setia, 2016).
This study looked at data between 2010 and 2016 and examined predictors of access to
immunizations using the systems-based approach. The relationship between the health system
indicators and vaccination coverage was assessed in this study. The exposure variables were
determined from standard sources like studies published in peer reviewed journals reports from
government/international agencies, UN reports, World Bank reports, etc.
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The study proposed to examine the trends of demographic factors indirectly linked to
health systems such as the region Human Development Index, Per capita Gross National
Income, GINI Index, Poverty Head Count Ratio at 1.9$ per day (2011 PPP), Total Fertility
Rate, Education Index, Adult Literacy Rate, Adult Female Literacy Rate, Official Development
Assistance(% GDP) Received. The outcome variables used were vaccination coverage over the
years in those respective countries, for BCG, DPT1, DPT3, OPV3, HBV3, HIB3 and Yellow
Fever. The relationship between the health system indicators and vaccination coverage was
assessed through the study. The exposure variables will be found out from standard sources like
studies published in peer-reviewed journals, reports from government/international agencies, UN
reports, World Bank reports etc. The vaccination coverage data used were taken from WHO &
UNICEF.
Study Variables
The study aimed to investigate associations between the independent variables, health
systems building blocks characteristics and access to immunizations, the dependent variable.
Franfort-Nachmias (2018) defines the dependent variable as the variable investigators are
seeking to explain, the object of the research while the independent variable is the variable
expected to account for the dependent variable. The independent variables that this study focused
on were governance, finance, information systems, health service delivery, vaccines and
socioeconomic indicators.
Three to four indicators under each of these building blocks were analyzed for
association to the outcome variable of this study, access to immunizations. The reason for
limiting the number of independent variables within each category was in order to avoid the
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possibility of there being too many variables to be analyzed under each building block, and due
to missing and insufficient data available in the dataset. The smaller number of variables selected
for analysis then formed the basis for generalization. The following immunizations were
proposed to be used as markers and proxies for immunizations BCG, DPT1, DPT3, OPV3,
HBV3, HIB3 and Yellow Fever.
Table 3
Total Variables Considered
Variables:

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Health Expenditure (% of GDP)
Govt. Health Expenditure (% of GDP)
Per capita Gross National Income
Official Development Assistance (% GDP) Received
Percentage of total expenditure on routine immunization financed
by government funds?
Physicians per 1000 population
Community Health Workers per 1000 population
Health care workers aware or vaccination schedules
Is there a stock-out at national level for BCG, DPT1, DPT3,
OPV3, HBV3, HIB3 and Yellow Fever
If yes, specify duration in months – BCG, DPT1, DPT3, OPV3,
HBV3, HIB3 and Yellow Fever Main cause for BCG stock-out,
Hep1, Hep2 Hep3 and PCV
Was the district level stockout linked to a national one for BCG,
DPT1, DPT3, OPV3, HBV3, HIB3 and Yellow Fever
Is there a stock-out in any district for BCG, DPT1, DPT3, OPV3,
HBV3, HIB3 and Yellow Fever
Vaccination services interrupted because of lack of vaccine for
BCG, DPT1, DPT3, OPV3, HBV3, HIB3 and Yellow Fever
Number of districts with DTP3 coverage categorized ( <50%, 5079%, 80-89%, > 90%)
% of districts with DTP3 coverage categorized <50%, 50-79%,
80-89%, > 90%, >=95%
% of districts with DTP3 coverage categorized <50%,
Drop-out rate between DTP1 and DTP3 coverage
% of districts with MCV2 coverage <50%, 50-79%, 80-89%, >
90%)
Has the country a Multi-Year Plan (MYP) for immunization?
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•
•

Has the country an annual workplan for immunization activities?
% of districts with micro plans including activities to raise
immunization coverage
Note. These are the total variables in all the domains of access considered

Research Design Connection to the Questions and Scientific Knowledge
This study was an ecological quantitative study that investigated the relationship between
access to immunization and health systems blocks using population data from 9 sub-Saharan
African countries. Past research has successfully used ecological studies for population studies
for examining and investigating relationships between variables. Using population data for
immunizations and not individual data and looking at trends, this research design was better
fitted to answer the research questions. This research design would lead to new evidence and
findings that can be used to strengthen immunization programs and inform policy. Ecological
studies are best tailored for such studies that support strengthening programs and policy work
(Setia, 2016).
As noted earlier in this chapter, there are few studies that l came across that had
investigated the relationship of access to immunizations using the health systems building
blocks, governance, human resources, information systems, service delivery and products. Using
secondary data is also a cheaper way of conducting such studies and also cuts on time (Setia,
2016).
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Methodology
Target Population
The target population used in this study, were 9- sub-Saharan countries, with data derived
from using data from the WHO/UNICEF Joint Reporting Form (JRF). These are global surveys
conducted by WHO and UNICEF using standard questionnaires that have been developed. One
characteristic is that the WUENIC data allows for comparison between countries and regions.
The JRF data is submitted to countries to collect data on systems performance every calendar
year, both WHO and UNICEF review this data for completeness and consistency, this provides
them to check the quality of the data and ask for any clarifications (WHO, 2020)
This study focused on data from 9- sub-Saharan African countries. The Multiple
Indicator Cluster Surveys (MICS) are surveys done by USAID that allow for international
comparisons by using more than 100 indicators that cover children and women in several areas
including health, education and gender (USAID, 2019).
A total of 9- countries were selected for the study, based on the consensus opinion of
public health experts consulted, who have extensive experience working in Africa and in terms
of the availability of data. The selection was made in order to provide the highest degree of
representativeness possible as it relates to this study's sample and the results obtained, and to
ensure maximum external validity. The countries selected for the study are at various stages of
socio-economic development and represent the various kinds of political systems on the
continent.
A single large data WHO/UNICEF dataset was used for the study. The dataset did not
have some exposure variables and therefore was complemented by health systems data from
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standard sources. The study covered multiple vaccines- BCG, DPT1, DPT3, OPV3, HBV3,
HIB3 and Yellow Fever
Settings
WHO- UNICEF has been providing support to countries to collect data on
children and women that countries can use to develop policies and intervention programs
addressing health (UNICEF, 2019). These surveys are developed by WHO/UNICEF in
collaboration with countries and are administered through face to face interviews. Country
Ministries of Health collect the data and are supported by WHO and UNICEF country offices if
they need it. Through joint collaboration WHO and UNICEF, both use a joint reporting form
(JRF) and aggregate the data that reduces the reporting burden of country members to fulfil their
mandate of using the data collected for monitoring health situations and trends (WHO, 2019).
This data is collected every year for the period January through December, which after
aggregation and evaluation is reported by WHO and made available on their website. This
collaboration is the basis of the WHO/UNICEF Estimates of National Immunization Coverage
(WUENIC). Information collected is also used in tracking and monitoring of global plans on
immunizations in particular the Global Vaccine Action Plan (GVAP) and the Regional Vaccine
Action Plans (RVAPs). Countries can also use this data to monitor their progress and for
planning purposes. It has key indicators that are very useful. This data is open source and is
available on the WHO website.
Sampling and Sampling Procedures
Sampling is the selection of a number of sampling units from a population of interest.
Using the purposive sampling technique, a total of 9 sub-Saharan African countries were selected
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for inclusion in this study, the Democratic Republic of Congo, Ethiopia, Ghana, Kenya, Malawi,
Rwanda, United Republic of Tanzania, Zambia, and Zimbabwe. This selection of countries was
chosen in order to allow for a sample that was as representative as possible and in order to ensure
maximum validity. The countries selected for this study are at various stages of socio-economic
development and represent the various kinds of political systems on the continent.
Procedures for Data Archival
The WHO/UNICEF dataset was used for this study, it included immunization coverage
by vaccine, access, financing, global immunization profiles, immunization schedules and
estimates based on quantitative data (WHO, 2019). Some exposure variables not in this dataset
were complemented by health systems data from standard sources. Additionally, some socioeconomic variables from sub-Saharan African countries were obtained from publicly available
sources such as the CIA website. Latest available data was harvested from these sources and
used for analysis. The project covered multiple vaccines- BCG, DPT1, DPT3, OPV3, HBV3,
HIB3 and Yellow Fever.
As indicated above, countries collect yearly data on public health indicators that are
reported to WHO and UNICEF. WHO and UNICEF have a collaboration that allows countries to
collect data using a joint reporting form (JRF) and aggregate the data that reduces the reporting
burden of country members to fulfil their mandate of using the data collected for monitoring
health situations and trends (WHO, 2019). Country offices for WHO and UNICEF help countries
with methodology or any challenges encountered if needed.
The DHS-USAID also collects data on countries and have datasets. They use
questionnaires with modeled questions which have been developed with countries having the
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options of adding their own questions across the fields that include demographics, child health,
anemia, service provider assessments, Malaria and HIV and AIDS (USAID, 2019).
Access to Datasets and Permissions
All 3 organizations UNICEF, WHO and USAID granted permission to use their datasets
after formally applying to them for permission. The application involved stating the reasons the
data going to be used for, the name of the institution l affiliate with and if there were
collaborating researchers. The application was made despite the datasets being available as open
access. This also provided the opportunity of asking for more data in case l needed it.
Instrumentation and operationalization of constructs
Despite the paucity of data the WHO/UNICEF dataset were used for this study with
complimentary data on health systems exposure variables from standard sources. The
WHO/UNICEF datasets have health systems building block indicators as defined by WHO. The
indicators are coded and point to health systems building blocks, governance, human resources,
finance, access to immunizations and service delivery. Seven vaccines were used as proxies for
some research questions, BCG, DPT1, DPT3, OPV3, HBV3, HIB3 and Yellow Fever.
Instrumentation and Operationalization of Constructs
The main source of the data used and reported to WHO and UNICEF is country data that
is collected by countries through a tool developed by WHO and UNICEF. All the 9- countries
included in this study report on common indicators that include vaccination coverage and health
systems indicators such as governance, financing, service delivery, supply chain factors such as
stock levels and stockouts. WHO and UNICEF report this yearly data on the WHO website and
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is archived with countries and institutions including individuals being able to use the data for
various causes. The data is reported under domains that include health systems building blocks.
Operationalization of Variables
Dependent Variable
The dependent variable for this study was access to immunization. Access has 4
dimensions namely accessibility, availability, affordability and acceptability. Access was
determined through information from the dataset on the rates of immunizations, stockouts,
whether the country had a Multi-Year Plan (MYP) for immunizations, coverage information for
each vaccine in percentages and % of districts with a specific vaccine coverage between defined
percentage points.
Independent Variables
The study used systems building blocks as independent variables: governance, finance,
information systems, health service delivery and vaccines. These variables were in the dataset
that was used.
Table 4
Health systems determinants of access to immunizations used for evaluating the study hypotheses
Indicators
Access to immunizations
Quality of Service Delivery

Variables
Is there a national system to monitor adverse
events following immunization?
Is there a national system to monitor adverse
events following immunization?
Is there a stock-out at national level for BCG
Is there a stock-out in any district for Measles
Physicians per 1000 population
Community Health Workers per 1000
population
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Has the country a Multi-Year Plan (MYP) for
immunization?
Is there a national system to monitor adverse
events following immunization?
Is there a stock-out at national level for BCG
Vaccine supply
Is there a stock-out at national level for DTP
Is there a stock-out at national level for
Measles
Are there line items in the national budget
Health Financing
specifically for the purchase of vaccines used
in routine immunizations?
Percentage of total expenditure on vaccines
financed by government funds
Overseas Development Assistance as % of
Select socioeconomic Factors
GNI ,
Health Expenditure as % of GDP,
Government Health Expenditure as % GDP,
GNI per capita
% of government funding of GDP
Note. The dependent and independent variables selected for the study
Governance

I proposed to use two options, the using the Mean- 1 Standard Deviation as cut-off. These
formed components of an indicator. If a country has all the variables (of the indicator) above the
cut-off values, we can classify it accordingly. For example, if Kenya had Physicians per 1000
population and Community Health workers per 1000 population above the cut-off values, we can
classify it as having adequate quality of healthcare delivery.
The 5 indicators were categorized as mentioned in the hypotheses below. The indicators
will not be assessed independently but a score will be created as mentioned above. A total score
will be computed of all the variables for each category and each variable will be converted into
dichotomous variables using descriptive statistics. For example, for assessing access using the
four dimensions l will use highly available or poorly available, poorly accessed or highly
accessible and highly affordable and poorly affordable.
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A change was made to these steps due to insufficient and incomplete data as discussed in
section 3. I did not use either Mean-1SD or Median Absolute Deviation for the final analysis, as
vaccination coverage was taken as a continuous variable for all the statistical aspects. Since there
is a large temporal difference (over 10 years) in the data, artificial cut-offs may not be
representative or valid. The initial idea was to convert vaccination coverage into categorical
variables (using cut-offs) and then do the analysis.
The selected indicators were representative of assessing access to immunizations using the health
systems blocks. IBM SPSS Statistics 25 software was used for both descriptive and inferential
analysis.
The variables that were finally used are in the table below. Most variables had
insignificant results to be included in the analysis.
Descriptive analysis proposed was to be done by converting dichotomous variables.
These variables were to be grouped into the building blocks and other health and developmental
indicators and were tested for association. In doing so initial diagnostic were conducted on these
data in order to check for accuracy, as well as any errors or duplicity of data. These data were
further analyzed through inferential statistics, which took the form of logistical regression
analyses.
Data Analysis Plan
Statistical Software
Data was analyzed by using the IBM SPSS Statistics 25 software package. The analyses
included both descriptive and inferential statistics.
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Data cleaning and screening procedures
Indicators were selected and narrowed down into the main health systems building
blocks. The following steps were executed, cleaning, coding of data and inputting into SPSS
software, production of frequency tables and exclusion of missing data and data deemed to be
outliers. Only data from the following countries were used Democratic People's Republic of
Congo, Ethiopia, Ghana, Kenya, Rwanda, Uganda, Tanzania, Zambia and Zimbabwe.
Research Question(s) and Hypotheses
The following are the research questions and hypotheses where used to determine
predictors of access to immunizations.
1. Is there a significant association between the quality of service delivery and access to
immunizations in nine sub-Saharan African countries?
H10: There is no significant association between the quality of service delivery and
access to immunizations in nine sub-Saharan African countries.
H1A: There is a significant association between the quality of service delivery and access
to immunizations in nine sub-Saharan African countries.
2. Is there a significant association between governance and access to immunizations in nine
sub-Saharan African countries?
H20: There is no significant association between governance and access to
immunizations.
H2A: There is a significant association between governance and access to immunizations.
3. Is there a significant association between vaccine supply and access to immunizations?
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H30: There is no significant association between vaccine supply and access to
immunizations.
H3A: There is significant association between vaccine supply and access to
immunizations.
4. Is there a significant association between health financing and access to immunizations in
nine sub-Saharan African countries?
H40: There is no significant association between health financing and access to
immunization in nine sub-Saharan African countries.
H4A: There is a significant association between health financing and access to
immunization in nine sub-Saharan African countries.
5. Is there significant association between socioeconomic factors and access to
immunizations in nine sub-Saharan African countries?
H50: There is no significant association between different socioeconomic factors and
access to immunizations in nine sub-Saharan African countries.
H5A: There is a significant association between socioeconomic factors and access to
immunizations in nine sub-Saharan African countries.
Statistical Analysis
Testing for Multicollinearity
Multicollinearity occurs when two or more independent variables have a high linear
correlation. The presence of multicollinearity in a regression analysis will result in the violation
of the basic assumptions of regression. In order to avoid this problem, it was proposed that
variance inflation factors (VIFs) be calculated in any cases where multiple independent variables
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were included in a single analysis. A VIF below five was deemed indicative of the absence of
high multicollinearity. However, as only a single predictor was found to achieve statistical
significance in these analyses, the calculation of VIFs was not necessary.
While the lack of high multicollinearity is an assumption of regression analysis, this was
not examined as part of the logistic regression analyses conducted in this study as these analyses
only include individual predictors. Multicollinearity can only be present with multiple
regression.

Checking for Outliers
I did check for outliers, these are values that are differ significantly from other values and
may affect the statistical inference (NIST, 2020). Both the mean and trimmed mean using SPSS
was used including plotting on box plot.
Descriptive Analysis
Descriptive analysis of data is performed to provide insights about the distribution and
the basic features of the various variables in a dataset. Essentially, descriptive analysis is the
generation of descriptive statistics which consists of measures of central tendency and
variability. The study variables that were used in this research were quantitative data. Some data
in the datasets were qualitative data that were converted into quantitative data. Frequency tables,
histograms and bar graphs were the outputs that were generated for these variables. The use of
frequencies allowed for the determination of the mode and also showed how the data are
distributed throughout the various categories of each variable.
Inferential Analysis
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Just as its name suggests, inferential analysis in research is performed to aid in providing
inferences on various phenomena. The most important inferential analysis proposed to be done
on the data was logistic regression. Logistic regression was used and the significant association
of variables was determined through a p-value of less than 0.05.
Binary logistic regressions were conducted for the dependent variable against the
independent variables. The dependent variable, access to immunization, is a dichotomous
variable that indicates whether a country has access to immunization or not. The independent
variable in this regression model were the components of the health system building blocks,
which included governance, service delivery, finance, quality of service delivery and human
resources. The analysis was conducted in two stages. In the first stage, each independent variable
was regressed against the dependent variable with all independent variables with significant
relationships selected. In the second stage, all the significant variables from the first stage were
planned to be included in a single multivariate logistic regression analysis alongside the
dependent variable. However, this second planned stage was not executed as only a single
independent variable was found to achieve statistical significance in the simple logistic
regression analyses conducted, obviating the need for a multivariate analysis.
Threats to Validity
External validity
This study involved the use of a sample to make a generalization to the population in
question, which provided external validity to the study. The sampling units that were used in this
study were selected using the purposive sampling technique. This procedure can lead to selection
bias, which consists of a threat to the study’s external validity. Selection bias can be encountered
during the selection of the sampling units. In research, the sampling units should have an
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attribute of interest that can be used to make generalization to the entire population. If a unit is
selected and does not possess this attribute, selection bias is introduced.
This study has some probability of selection bias due to a limited number of countries
being included in the final data sets. This was reduced by including 9 countries in the study and
making the country selection as representative as possible. The probability of information bias
was felt to be low as the data were taken from standard sources. Also, multiple estimates of
vaccination coverage were used in the final analysis in order to reduce biased information. The
possibility of confounding was planned to be reduced by the use of multivariable regression
modeling, while due to only a single independent variable achieving statistical significance in
these analyses, this final planned model was not run. Additionally, an examination of the
literature did not reveal any other confounders or control variables, and so no other potential
confounding or control variables were included in this study.
Internal validity
In order to make reasonable conclusions, sound research has to be conducted. Internal
validity is concerned with the number of confounding variables that are found in a study. A high
number of confounding factors greatly compromises the meaning and sense that can be derived
from a particular research. Therefore, it is vital to ensure that the confounding effect has been
reduced to the lowest level possible. Having high internal validity is essential as it leads to
results that are consistent if the study is repeated. To increase the internal validity in this study,
factors that can cause confounding were also included in the study.
Statistical conclusion validity
Achieving statistical validity is important to reach conclusions in a study, a failure to
achieve statistical validity can occur when statistical significance is not reached due to
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insufficient data or deviations from (Creswell, 2013). In order to have sufficient data, 9countries were selected and the number of years of focus increased for this reason.
Ethical Considerations
An application was made to the Walden Institutional Review Board before data was
reviewed and used. To fulfil one of the requirements, l completed the training offered by the
National Institute of Health Office of Extramural Research that helps researchers working with
human subjects to learn how to handle human subject data and ensure confidentiality. The
certificate of completion was submitted to the Walden Institutional Review Board as part of the
application process. The data used had no individual identifiers as it was country data used.
Protection of Participants Rights
The data that was used was country level data that had no individual identifiers at all.
This data was country level aggregated data collected by the Ministry of Health with no
individual identifiers that would identify individuals and violate any human rights. Both
descriptive and inferential statistics were proposed to be used.
Data Protection
Data will be saved with security code protection both on my laptop and an external hard
drive. The data will be kept for 5 years after graduating and will be destroyed using the
recommended procedures.

Summary
This quantitative ecological study used the health systems building blocks to examine the
strength of their association to access to immunizations in nine sub-Saharan African countries.
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The dependent variable was access to immunizations while the independent variables were
financing, governance, human resources, vaccines, service delivery and some socioeconomic
factors based on country indices such as GNI, GDP. The study was approved by the IRB of
Walden University after meeting all the requirements.
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Section 3: Presentation of Results and Findings.
Introduction
As stated in Section 1, the purpose of this study was to examine the association of health
systems building blocks as predictors of access to immunization in 9 sub-Saharan African (SSA)
countries. The research questions and hypotheses included in this study consisted of the
following:
1. Is there a significant association between the quality of service delivery and access to
immunizations in nine sub-Saharan African countries?
H10: There is no significant association between the quality of service delivery and
access to immunizations in nine sub-Saharan African countries.
H1A: There is a significant association between the quality of service delivery and access
to immunizations in nine sub-Saharan African countries.
2. Is there a significant association between governance and access to immunizations in nine
sub-Saharan African countries?
H20: There is no significant association between governance and access to
immunizations.
H2A: There is a significant association between governance and access to immunizations.
3. Is there a significant association between vaccine supply and access to immunizations?
H30: There is no significant association between vaccine supply and access to
immunizations.
H3A: There is a significant association between vaccine supply and access to
immunizations.
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4. Is there a significant association between health financing and access to immunizations in
nine sub-Saharan African countries?
H40: There is no significant association between health financing and access to
immunization in nine sub-Saharan African countries.
H4A: There is a significant association between health financing and access to
immunization in nine sub-Saharan African countries.
5. Is there a significant association between socioeconomic factors and health financing
access to immunizations in nine sub-Saharan African countries?
H50: There is no significant association between socioeconomic factors and access to
immunization in nine sub-Saharan African countries.
H5A: There is a significant association between socioeconomic factors and access to
immunization in nine sub-Saharan African countries.
In this chapter, the results of the analyses conducted for this study are presented and
discussed. This consists of a set of descriptive statistics conducted on the dependent and
independent variables included in this study, followed by a series of logistic regression analyses.
The dependent variable was access to immunizations while the independent variables included
health systems building blocks, health service delivery, governance, vaccine supply and health
financing. The descriptive statistics conducted consisted of frequencies and percentages
associated with each response category in relation to all categorical variables of interest, with
measures of central tendency and variability calculated and reported for the one continuous
measure included in this study.
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These analyses are followed by simple logistic regression analyses, with one analysis
conducted in relation to each independent variable. A multiple logistic regression analysis was
also planned, but was not run as only a single independent variable was found to achieve
statistical significance in the simple logistic regression analyses conducted for most variables
except socioeconomic variables. Finally, a summary is presented, which briefly summarizes this
study's results, and also discusses these findings in relation to this study's research questions and
hypotheses.
Data Collection of Secondary Data Set
The source of data used in this study consisted of data derived from the annual
WHO/UNICEF Joint Reporting Form. The time frame for data collection was 1997 to 2018. This
is a population-based survey, with sampling suggested at one or more stages such that a
representative sample of the population is achieved. WHOs member states report data every year
following a designed methodology and questionnaire by both WHO and UNICEF. WHO and
UNICEF request for data from January to December each year through written communication
with Member States, which they extract, reviews to assure completeness and accuracy (WHO,
2020). Although the WHO provides sampling recommendations and guidelines, actual
recruitment and response rates varied from country to country. The data tools used are
standardized while countries can make adjustments by adding extra data they might need.
A number of discrepancies were present between the use of the secondary dataset as
proposed, and what was actually done. First, regarding the range in years used in these analyses,
due to the small sample size included in these data, this was expanded from 2010 to 2016 to
1997 to 2018. The number of indicators examined under each independent variable, varied but
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were not three to four in all cases as planned. Additionally, the full list of immunizations
proposed, which consisted of BCG, DPT1, DPT3, OPV3, HBV3, HIB3 and Yellow Fever, were
not all incorporated into these analyses, including some socio-economic variables also
incorporated into these analyses. Some of these vaccines data was insufficient not to provide any
statistical significance.
The dependent variable chosen specifically related to whether the country has a Multi-Year
Plan (MYP) for immunization. The final set of independent variables analyzed differed
significantly from the list of those included in the tables in Section 2. This was due to lack and
minimal data for analysis. Finally, variables were not dichotomized for the purposed of these
analyses so that statistical power would not be reduced.
Data used for human resources related to BCG and DPT1 immunizations obtained from the
WUNEIC dataset for the same years.
Regarding the representativeness of this sample, methods used varied from country to
country, with the WHO and UNICEF only providing recommendations with regard to the
sampling used. Similarly, response rates also varied from country to country. Implementation of
the WHO's recommendations would provide for representative samples.
Inclusion and Exclusion Criteria
This study focused on sub-Saharan Africa due to the large incidence of disease in this
portion of Africa that is preventable by vaccines. This portion of the continent was also focused
upon as a delimitation determined by the researcher due to the current gaps in knowledge present
in this area when focusing on sub-Saharan Africa. Purposive sampling was used in order to select
a total of nine sub-Saharan African countries, with this sampling method chosen in order to
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produce a sample that was representative of sub-Saharan Africa and with the sample being valid.
All countries outside of the researcher's area of interest was excluded from this study. All the
data in the WHO/UNICEF dataset was included in the study.
Review of Statistical Assumptions.
The statistical analysis included the dependent variable access to immunizations and the
independent variables governance, quality of service delivery, financing, vaccine supply and
socioeconomic factors. A review was conducted of the missing data, multicollinearity and any
outliers. This review did not show any outliers.
Descriptive Statistics
Initially, a series of descriptive statistics were conducted on the dependent and
independent variables of interest included in this study. Access to immunizations consisted of the
dependent variable included in this study, while independent variables fell under the categories
of Quality of Service Delivery, Governance, Vaccine Supply, and Health Financing. Table 4
reports the frequencies and percentages of response associated with all categorical measures of
interest, which included all measures with the exception of GSA_06172, which was continuous.
First, with respect to whether the country has a Multi-Year Plan (MYP) for immunization
(GSA_01001), slightly over 3% of the sample had a response of "No," with close to 97% having
a response of "Yes."
Regarding Quality of Service Delivery, these measures consisted of the following: Is
there a national system to monitor adverse events following immunization? (GSA_05160), Is
there a stock-out at national level for BCG? (GSA_13198), Is there a stock-out at national level
for DTP? (GSA_13204), and Is there a stock-out in any district for Measles? (GSA_13249).
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First, with respect to whether there is a national system to monitor adverse events following
immunization, this was "No" in slightly above 17% of cases and was "Yes" in close to 83% of
cases. Next, regarding whether there is a stock-out at national level for BCG, this was "No" in
slightly above 78% of cases, and was "Yes" in close to 22% of cases. Next, with respect to
whether there was a stock-out at national level for DTP, responses were "No" in slightly above
85% of cases, and "Yes" in close to 15% of cases. Finally, with respect to whether there was a
stock-out in any district for Measles, this was "No" in close to 81% of cases and was "Yes" in
slightly above 19% of cases.
Next, with respect to Governance, the measures of GSA_01001 (Has the country a MultiYear Plan (MYP) for immunization?) and GSA_05160 (Is there a national system to monitor
adverse events following immunization?) were included. However, GSA_01001 consisted of the
dependent variable in these analyses and so was not duplicated in Table 4. In addition,
GSA_05160 was already categorized under Quality of Service Delivery and is also not
duplicated in Table 4.
Regarding Vaccine Supply, these measures consisted of GSA_13198 (Is there a stock-out
at national level for BCG?), GSA_13204 (Is there a stock-out at national level for DTP?), and
GSA_13246 (Is there a stock-out at national level for Measles?). As GSA_13198 and
GSA_13204 were already categorized under Quality of Service Delivery, these results will not
be duplicated here. Regarding whether there was a stock-out at national level for Measles, this
was "No" in slightly over 88% of cases, and "Yes" in close to 12% of cases.
Finally, regarding Health Financing, these measures consisted of GSA_06167 (Are there
line items in the national budget specifically for the purchase of vaccines used in routine
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immunizations?) and GSA_06172 (Percentage of total expenditure on vaccines financed by
government funds). Regarding whether there were items in the national budget specifically for
the purchase of vaccines used in routine immunizations, this was "No" in slightly above 10% of
cases, and "Yes" in close to 90% of cases.

Measures of central tendency and variability were

instead conducted in relation to GSA_06172, the only continuous measure included in this
study's logistic regression analyses. This measure was found to have a mean of 21.092% (SD =
26.509%), with a median of 11.500%, and a mode of 0%. A range of 100% was found, with a
minimum of 0% and a maximum of 100%.
The descriptive statistics included in this table include all dependent and independent
variables included in this study’s analyses. As they were all dichotomous, there is no additional
descriptive data to report.
Table 5
Descriptive Statistics: Frequencies
Measure

No

Yes

N

Valid %

N

Valid %

Dependent Variable
GSA_01001

6

3.279%

177

96.721%

Quality of Service Delivery
GSA_05160
GSA_13198
GSA_13204
GSA_13249

31
109
108
92

17.318%
78.417%
85.039%
80.702%

148
30
19
22

82.682%
21.583%
14.961%
19.298%

Vaccine Supply
GSA_13246

120

88.235%

16

11.765%

Health Financing
GSA_06167

18

10.112%

160

89.888%
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Measure

Indicators

Dependent Variable
GSA_01001

Has the country a Multi-Year Plan (MYP) for
immunization?

Independent Variable
Quality of Service Delivery
GSA_05160

Is there a national system to monitor adverse
events following immunization?

GSA_13198

Is there a stock-out at national level for BCG

GSA_13204

Is there a stock-out at national level for DTP
Is there a stock-out at national level for Measles

GSA_13249
Vaccine Supply
GSA_13246

Is there a stock-out at national level for Measles

Health Financing
GSA_06167

Are there line items in the national budget
specifically for the purchase of vaccines used in
routine immunizations?

Logistic Regression Analyses: Introduction
A series of simple logistic regression analyses were conducted with access to
immunizations as the dependent variable, and with each independent variable of interest included
individually in each logistic regression model. While a multiple logistic regression analysis was
planned following these analyses, only a single predictor was found to achieve statistical
significance out of all predictors analyzed, which made this final analysis unnecessary.

67
Research Question 1
Is there a significant association between the quality of service delivery and access to
immunizations in nine sub-Saharan African countries?
H10: There is no significant association between the quality of service delivery and
access to immunizations in nine sub-Saharan African countries.
H1A: There is a significant association between the quality of service delivery and access
to immunizations in nine sub-Saharan African countries.
The first set of simple logistic regression analyses were conducted with the measures of
interest associated with Quality of Service Delivery. These consisted of the following: Is there a
national system to monitor adverse events following immunization? (GSA_05160), Is there a
stock-out at national level for BCG? (GSA_13198), Is there a stock-out at national level for
DTP? (GSA_13204), and Is there a stock-out in any district for Measles? (GSA_13249).
Table 6 presents the results of these analyses. As shown, statistical significance was only
found with respect to the effect of GSA_05160, Is there a national system to monitor adverse
events following immunization? An odds ratio of 21.630 was found, indicating that the presence
of a national system to monitor adverse events following immunization was associated with an
odd of the country having a Multi-Year Plan (MYP) for immunization that were increased by a
factor of 21.630. The 95% confidence interval for this predictor's odds ratio was found to be very
wide, ranging from 2.327 to 201.040. This reflects a higher degree of variability and reduced
precision with respect to the point estimate of this particular odds ratio. In terms of predictors
that were found to achieve statistical significance, only in this case was the 95% confidence
interval found to be very wide. As indicated in the notes of this table, this logistic regression
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model was found to achieve statistical significance, with a Cox & Snell R2 of .053 being found,
along with a Nagelkerke R2 of .236.
Table 6
Logistic Regression Analyses With Quality of Service Delivery
B (SE)

Wald χ2 (df)

OR

GSA_05160a

3.074 (1.137)

7.303** (1)

21.630

GSA_13198b

-.612 (1.243)

.243 (1)

.542

.047

6.190

.000 (1)

46156424.081

0.000

─

1.044 (1)

.231

.014

3.841

Measure

GSA_13204c

17.648 (9220.900)

GSA_13249d

-1.466 (1.435)

95% CI for OR
Lower
Upper
2.327
201.040

Note. *p<.05, **p<.01, ***p<.001. GSA_05160 = National Adverse Event Monitoring System,
GSA_13198 = Stockout at National Level for BCG, GSA_13204 Stockout of DPT at National
Level, GSA_13249 = Stock-out at National Level for Measles,
Research Question 2
Is there a significant association between governance and access to immunizations in nine
sub-Saharan African countries?
H20: There is no significant association between governance and access to
immunizations.
H2A: There is a significant association between governance and access to immunizations
Next, with respect to Governance, after filtering and removing unusable variables from
those proposed, the measures of GSA_01001 (Has the country a Multi-Year Plan (MYP) for
immunization?) and GSA_05160 (Is there a national system to monitor adverse events following
immunization?) were retained. However, GSA_01001 consisted of the dependent variable in
these analyses and so could not also be included in these analyses as an independent variable,
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while GSA_05160 was previously examined as an independent variable with respect to Quality
of Service Delivery. Therefore, no new results are presented here.
Research Question 3
Is there a significant association between vaccine supply and access to immunizations?
H30: There is no significant association between vaccine supply and access to
immunizations.
H3A: There is a significant association between vaccine supply and access to
immunizations.
The following analyses focused upon Vaccine Supply. The independent variables
associated with Vaccine Supply consisted of GSA_13198 (Is there a stock-out at national level
for BCG?), GSA_13204 (Is there a stock-out at national level for DTP?), and GSA_13246 (Is
there a stock-out at national level for Measles?). As GSA_13198 and GSA_13204 were
previously examined, these results will not be repeated here, with the results of the remaining
model presented in Table 7. As shown, this measure was not found to achieve statistical
significance, with this logistic regression model also not found to achieve statistical significance.
Table 7
Logistic Regression Analysis With Vaccine Supply
Measure
GSA_13246

B (SE)
-1.369 (1.255)

Wald χ2 (df)

OR

1.191 (1)

.254

GSA_13246 Stockout at National Level for Measles

95% CI for OR
Lower
Upper
.022
2.975
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Research Question 4
Is there a significant association between health financing and access to immunizations in
nine sub-Saharan African countries?
H40: There is no significant association between health financing and access to
immunization in nine sub-Saharan African countries.
H4A: There is a significant association between health financing and access to
immunization in nine sub-Saharan African countries.
The other set of logistic regression analyses conducted focused upon Health Financing,
with the independent variables of interest analyzed consisting of GSA_06167 (Are there line
items in the national budget specifically for the purchase of vaccines used in routine
immunizations?) and GSA_06172 (Percentage of total expenditure on vaccines financed by
government funds). As shown in Table 8, neither of these independent variables were found to
achieve statistical significance, with neither of these logistic regression models found to achieve
statistical significance.
Table 8
Logistic Regression Analyses With Health Financing
Measure

B (SE)

Wald χ2 (df)

OR

GSA_06167a

.661 (1.126)

.345 (1)

1.937

GSA_06172b

.014 (.031)

.212 (1)

1.015

95% CI for OR
Lower
Upper
.213
17.624
.954

1.079

GSA_06167 = National Budget line for Vaccine Purchase, GSA_06172 = Percentage of Total
Expenditure on Vaccines financed by government funds
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Research Question 5
Is there a significant association between socioeconomic factors and health access to
immunizations in nine sub-Saharan African countries?
H50: There is no significant association between socioeconomic factors and access to
immunization in nine sub-Saharan African countries.
H5A: There is a significant association between socioeconomic factors and access to
immunization in nine sub-Saharan African countries.
A multiple regression analysis was conducted for the socioeconomic variables using BCG
vaccine as the proxy Overseas Development Assistance as % of GNI , Health Expenditure as %
of GDP, Government Health Expenditure as % GDP, GNI per capita and % of government
funding of GDP. The Overseas Development Assistance as % of GNI has a p-value <0.05 just as
the GNI per capita and % Government funding for vaccination showing strong evidence against
the null hypothesis. This shows that there is a significant association between ODA% of GNI,
GNI per capita, % Government funding for vaccination and access to immunization. These are
good predictors of immunization coverage.
Health Expenditure as % of GDP and Government Health Expenditure as % of GDP had
the p-value greater than 0.05 showing that we accept the null hypothesis. There was significant
association between Health Expenditure as % of GDP, Government Expenditure and access to
immunization. BCG coverage and Health Care Worker per 1000 population and BCG Coverage
and Doctor per 1000 population were strongly associated with access to immunization leading to
the rejection of the null hypothesis just as the similar indicators for DPT1, DPT1 Coverage and
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Health worker per 1000 population and BCG Coverage and Doctor per 1000 population. These
results shown a strong association between socioeconomic factors and access to immunizations.

Table 9
Multiple Linear Regression models to predict vaccine coverage
BCG coverage
Variables in the model

Unstandardized
Beta Coefficient
1.432

Standardized
Beta coefficient
0.668

t-test value

P value

3.022

0.006

Overseas Development
Assistance as % of GNI
Health Expenditure as %
of GDP
Government Health
Expenditure as % of GDP
GNI per capita

0.725

0.402

2.223

0.036

0.344

0.092

0.398

0.694

-1.312

-0.136

-0.628

0.536

0.017

0.714

3.670

0.001

% Government funding
for vaccination
BCG Stockouts

0.259

0.746

3.716

0.001

-2.376

-0.127

-0.886

0.385

Constant

-2815.551

-2.995

0.007

Year

R square- 0.681, Durbin Watson- 1.648, ANOVA: F-7.319 p value <0.001
The table shows significant results for overseas development assistance as a percentage of GNI,
GNI per capita, and the percentage of government funding for vaccination
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Table 10
Correlation between Vaccination Coverage and Baseline Variables
BCG
Variables
BCG Coverage and Health worker per 1000
population
BCG Coverage and Doctor per 1000 population

Correlation
Coefficient
0.667

P value

0.928

<0.001

Correlation
Coefficient
0.597

P value

0.892

<0.001

0.009

Table 11
DPT1
Variables
DPT1 Coverage and Health worker per 1000
population
DPT1 Coverage and Doctor per 1000 population

0.024

Summary
The results of the logistic regression analyses indicate that the null hypotheses relating to
the Quality of Service Delivery and Governance, which relate to Hypotheses 1 and 2,
respectively, were rejected as the predictor "Is there a national system to monitor adverse events
following immunization?," which was included in both of these categories, achieved statistical
significance. Hypothesis 5 also indicated that the null hypothesis relating to socioeconomic
factors was rejected as predictors, DPT1 Coverage and % district vaccination, DPT1 Coverage
and Doctor per 1000 population, and ODA as % of GNI showed strong association to access to
immunization.
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As no other predictors were found to achieve statistical significance, null hypotheses
three and four were not rejected. With respect to this study's research questions, these results did
indicate a significant association between the quality of service delivery and access to
immunizations in nine sub-Saharan African countries, as well as a significant association
between governance and access to immunizations in the nine sub-Saharan African countries.
The results of the logistic regression analyses conducted for this study only found
statistical significance with respect to the effect of whether there is a national system to monitor
adverse events following immunization, with this having a strong and positive impact upon
whether the country has a Multi-Year Plan (MYP) for immunization. The following chapter will
discuss these results in relation to previous literature and theory, as well as the limitations of the
study and possibilities for future research.
The results also showed statistical significance with some socioeconomic factors
significant, the Overseas Development Assistance as % of GNI, GNI per capita and %
Government funding as predictors for vaccination coverage. Some socioeconomic factors thus
showed significance in this study while others did not. Additionally, this following chapter will
also discuss implications and conclusions associated with this study's results. The following
chapter will discuss these results in relation to previous literature and theory, as well as the
limitations of the study and possibilities for future research.
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Section 4: Application to Professional Practice and Implications for Social Change Introduction
Interpretation of the Findings
This study was an ecological quantitative study that used secondary data from WHO and
UNICEF. It examined the association between health systems building blocks and access to
immunization. Immunizations are one of the most successful public health interventions but
unfortunately sub-Saharan African countries remain below the global targets. This contributes to
the high morbidity and mortality especially for children under the age of 5.
Interpretations of findings
Study Findings and Past Research
Quality of service delivery. The study examined the strength of association between the
quality of service delivery and access to immunizations in nine sub-Saharan African countries.
The variables that were investigated include: Is there a national system to monitor adverse events
following immunization? Is there a stock-out at national level for BCG? , Is there a stock-out at
national level for DTP? and Is there a stock-out in any district for Measles?
The logistic regression analysis showed a predictive relationship between the quality of
service delivery and access to immunizations in sub-Saharan African countries. With increased
quality of service delivery access to immunizations goes up. This study supports findings from
other studies that have looked at this. Lahariya (2015), showed that states with improved service
delivery had improved access to immunizations than states who did not. Malande et al (2019)
identified service delivery as one of the determinants to access to immunizations in a rural
district in Uganda. Service delivery focusing on stock levels and community reach out was one
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component of the strategy to increase access and uptake at community level where uptake is low
(Shikuku et al, 2019).
Amponsa-Dacosta supported the findings of this study by reporting a number of factors
that affected the quality of service thus affecting access to immunizations. Among the constraints
in sub-Saharan Africa to access to immunizations, health resources constraints, supply chain
functions, how far health facilities that had the HPV vaccine, the focus of the study and programs
that targeted communities (Amponsah-Dacosta, Kagina & Olivier, 2020). Peck et al (2018)
looking at global vaccination coverage had findings that support my study findings, barriers to
access to immunizations include hard to reach populations, supply factors such as service
delivery and stock levels of vaccines. They gave an example of the dropout rate of DPT1 to
DPT3 in 2018 where the dropout rate was highest in the African region 10% compared to the
West Pacific Region at 1% (Peck, et al, 2018).
Ako et al (2016) is another study that supports my findings how the quality of service
delivery is a predictor for access to immunization. The study was conducted in one of the largest
districts in west Cameroon and looked at human resources, availability of vaccine essential
resources and the knowledge of health personnel on vaccines and cold chain development. Their
results showed major gaps in all these areas and concluded that in order to improve access
strengthening was required in knowledge, availability of vaccines, cold chain and outreach
programs.
Ankrah, Darko, Sabblah, Mantel-Teeuwisse & Leufkens (2018) study supports the
findings of this study regarding the strong association of reporting adverse events following
vaccines through a study they conducted in Ghana on reporting of adverse events following
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immunization. Following adverse events after immunizations especially within the week is
important in assuring patient safety, monitoring any adverse events and assuring confidence to
the patient and community. Immunizations are a very sensitive subject in most communities and
any report of adverse events can derail an immunization program.
Findings from the study that looked at the relationship between facility-Based delivery
and infant immunization in sub-Saharan Africa showed a strong relationship between facility
delivery and immunization (Moyer, Benyas & Rominski, 2016). They also showed social factors
related to facility delivery as service delivery and immunization. Additional findings are quite
critical in supporting the systems approach of this study where they looked at governance and its
holistic role of touching on other health systems building blocks, human resources and capacity,
health and employment and the ability to draw knowledge and values that would lead to health
service delivery (Moyer, Benyas & Rominski, 2016).
Some studies included human resources under the quality delivery of services,. There was
a strong association for the number of health care workers and doctors per 1000 population.
Having more health workers and doctors increased access to immunizations. Malande et al
(2019), showed lower immunization rates with overwhelmed staff due to understaffing and
recommended increasing health care workers to increase access to immunizations. Brandy &
Biggs (2019) also complement my findings with their results that showed lower immunization
rates with low staffing levels and that high staff levels would lead to increased access.
Amponsah-Dacosta, Kagina & Olivier (2020) showed that the size and knowledge of health
workers was one of the keys to increasing access, areas with staff who were not knowledgeable

78
about the HPV, which was the focus of the study, had low access compared to those with more
staff and knowledge about the vaccine. This is another study that supports my findings.
Governance and access to immunization. The study showed governance as a strong
predictor to access to immunization. Countries with strong governance structures are more likely
to have increased access to immunization than those without. Countries with Multi-Year Plans
(MYPs), one governance function, were more likely to have higher access to immunizations than
the ones without. Countries use MYPs as their strategies for immunizations in the country, for
planning to increase immunizations, inform supply chain functions, budgetary allocation,
resource mobilization and other resources. Mihigo, Okeibunar, Anya, Mkanda & Zawaira (2018)
had similar findings to this study, attributing increased access to immunization in African
countries over the last few years to strengthened Multi-Year Plans (MYP) and the presence of
the National Immunization Technical Advisory Groups (NITAG) that advise policy. Petu (2018)
had similar findings showing increasing trends of access for countries with cMYPs that led to
better management functions such as procurement and distribution of immunizations.
In India, Gurnani et al (2018), reported an increase in immunization rates of 6.7%
through the Intensified Mission Indradhanush (IMI) program instituted by the Ministry of Health
and Welfare. This supports the importance of planning and having MYPs in place down to the
region and district levels. These findings support efforts in African countries by donor
communities to encourage MYPs and the formation of the National Immunization Technical
Advisory Group (NITAG), that would support policies, planning and implementation of
immunization programs (Mihigo, Okeibunar, Anya, Mkanda & Zawaira, 2018). AmponsahDacosta, Kagina & Olivier (2020) also support these findings as they noted in their study clear
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governance structures that include the National Immunization Programs to increase access to
immunizations. Anya, Okeibunor, Mihigo, Poy, Zawaira (2018) equally attributed poor
governance to affecting immunizations in African countries in their study.
Part of the governance functions is to put in place policies that assure quality and safety
of immunizations of which adverse events are one. One way to increase access to immunizations
is through mandatory provisions through legislation, even in this case, governance functions that
support procurement functions, access, planning are still critical (MacDonald et al, 2018).
Additionally, the findings also would support the use of MYPs as instruments for
resource mobilization for both GAVI and non-GAVI countries. The MYPs also show the various
contributions of funders including government that provide valuable information for planning
purposes and resource mobilization. Clearly addressing governance key functions such as policy
setting, planning, supply chain functions and human resources would promote access to
immunizations (Songane, 2017).
Vaccine Supply. Vaccine supply was not found to be statistically significant as a
predictor for immunizations. There are reasons that might explain this that include vaccination
hesitancy, where religious, social and personal beliefs towards immunizations might play a part.
It could also be the fact that immunizations are supplied through national programs that might
impact availability of vaccines. The result could also support the belief that there are several
other predictors for immunization which are complex and a combination of them might play a
part in explaining this finding including the health systems building blocks.
These findings however differ from some studies, Bangura, Xiao, Qiu, Feiyun & Chen
(2020) in their study noted that among the barriers to immunizations were parent factors and
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vaccine supply factors. van den Ent et al (2017) in their study, equally attributed the low
immunization rates in Madagascar to several factors that included supply chain factors such as
stockouts. Grandy & Biggs (2019) had similar findings in their study that weak policies, vaccine
supply systems, stockouts affected access to immunizations especially in countries affected by
violence and displaced communities. This was a similar observation in a study that looked at
barriers to uptake and provision of immunization in a rural district in Uganda, low stocks and
stockouts led to low immunization rates, for measles the uptake for was only 65.5% (Malande et
al, 2019). Another study conducted in Cameroon reached the same conclusions around vaccine
supplies, availability of immunizations being a predictor to access to immunization among other
factors (Akoh et al, 2016).
Costa, Weber, Darmstadt, Abdalla, & Victora (2020) in their study found religious
factors to have influenced access to immunizations with lower uptake among Muslims than
Christians and not availability of vaccines. This supports the findings of this study that vaccine
supply alone is not a predictor to immunizations even when vaccines are available uptake can be
low due to other factors such as religious affiliation and beliefs. While some studies and surveys
have shown availability of immunizations such as the Multiple Indicator Cluster for Nigeria
2016-2017 in 14% of children were not fully vaccinated due supply factors such as lack of
vaccines, Sato (2020), showed in his study that in some regions of Nigeria stockouts where
predictors of immunization while some regions similar findings to this study were observed.
My findings show while vaccine supply was not a significant predictor to access, there
many reasons and factors that need to be looked in to understand this and increase immunization
rates.
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Financing. The study examined the association between Health Financing and access to
immunization. The study showed that there was no significant association between health
financing by countries and access to immunization (p>0.05). Countries that had a budget line for
procurement of vaccines and also the percentage of total expenditure. This finding is supported
by Michingaindze, Wiysonge & Hussey (2013) study that showed similar findings and attributed
this to the lack of financing by governments despite having a budget line for vaccines in their
budgets. The reason is that while the budget lines were provided for, the funds were not released.
Giffiths et al (2020) looked at immunization budget lines in 33 African countries and some of
their findings included disparities in the budget lines and actual execution reported to WHO this
was >50% in 84% of the countries. They also observed that 44% of the countries did not have a
budget line despite reporting to WHO its existence and budgeted and executed figures were
different with executed figures being lower (Giffiths et al, 2020). This could explain and
supports the finding of this study that did not show significance association between financing
and access to immunizations.
GAVI support to African countries could be one reason that could explain this finding as
most are still recipients and having budget lines may not significantly improve procurement of
vaccines and access by extension. Sambala & et al (2019) tested whether GAVI eligible
countries were more likely to introduce new and underutilized vaccines (NUVs) between 2010
and 2017 than non-GAVI countries. They found that there was no statistical significance
relationship, similar to what my study found. Peck et al (2019) also showed the difference that
GAVI funding made in increasing immunization rates of PCV and DPT3 in 79% of African
countries.
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However, Onishchenko et al (2018) in their study looking at trends in vaccines in
different countries reached a different conclusion by showing a correlation between increased
sustainable funding for vaccines with immunization access and availability. They found though
lower access for newer vaccines attributing that to increased costs (Onishchenko, 2018). This
could support that GAVI and ODA funding skews and may lead to different conclusions
regarding financing and access to immunizations in LIMCs.
Socioeconomic Factors. The study showed that there was a significant association
between certain determinants of health and access to immunizations that relate to financing.
These social determinants are Overseas Development Assistance as % of GNI, GNI per capita
and % Government funding for vaccination. This finding is supported by a study by
Onishchenko et al (2019) showed a strong positive association the scope of immunization and
funding for vaccination between 2006 and 2016. The same finding applied to the GNI per capita
and % Government funding for vaccines in middle-income countries that are not GAVI
recipients (Onishchenko, 2019). Where the governments had higher income they were more
likely to earmark more funds to vaccine procurement and immunization programs.
While there weren’t studies l came across that showed direct expenditure on
immunizations from ODA, the association could probably be explained as funds that are
included in the total health expenditure which in most countries has gone up in African countries.
Shajalal et tal (2017) showed how China’s contribution has grown over the years in its assistance to
African countries with the health sector being one of the benefiting areas with Mother and Child Health
among the main beneficiaries. In their study Ikilezi, Augusto, Dieleman, Sherr, & Lim. (2020) in

their study showed how donor assistance for health (DAH) had grown between 1990 and 2016
totaling $34.5 billion for African countries of which $22.1 billion was channeled directly to
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DAH. This could explain partly the result of my study. Ikilezi et al (2020) finds support a strong
association between higher amounts of developmental aid towards immunizations and improved
DPT3 vaccine coverage in Africa.
Limitations
The use of secondary data pauses the limitation that the data’s objective for which it was
collected may be different from the objective of the researcher who wants to use it. This was one
of my limitation. The other limitation was the missing data for certain variables and insufficiency
that made me drop certain variables that would have been used. This paused a limitation in using
more valuables that would have been used for statistical analysis and contributed to the
adjustments in methodology.
The use of country data also paused the limitation that it did not provide individual data
and factors that would have been important in understanding predictors to immunization at the
individual level and how that feeds into the national data. Part of understanding and
strengthening health systems is to increase access to immunization taking into consideration
individual factors as some studies have shown (Bangura & Xiao, 2019).
The other limitation of the study is that access to immunization in a country may be
different between regions and districts. The secondary data used for this study by WHO and
UNICEFF, only looks at national data and does not take into consideration the differences
between regions or districts and provide for better understanding or predictors in different
districts and regions. Eboreime, Abimbola & Bozzani (2015) showed disparities in access to
immunizations and rates by looking at 2 regions in Nigeria. Different factors can predict access
to immunizations in the different regions of the same countries.
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Recommendations for Further Research
The study examined the strength of association of health systems building blocks and
access to immunizations in 9 sub-Saharan African countries The study highlighted the
importance of governance, service delivery, human resources and some economic indicators in
increasing access to immunizations to reach national and global targets. The importance of
having national yearly plans that takes into consideration the resources and different
characteristics of the country and its region. The study also highlighted the need for a plan that
takes into consideration safety by monitoring adverse events of immunizations.
Service delivery was another predictor the study highlighted that is a predictor of access
to immunizations. The study did not however look at the individual countries and individual
predictors. This is one area that future studies should look at. Future studies should also look into
incorporating more variables into the study. Human resources- health workers and doctors are
critical and essential to access to immunizations. Beyond looking at each individual building
blocks the study showed how they all need to work together to increase immunizations in subSaharan African countries. While some might show strong association to access it nevertheless
doesn’t discount the others.
The ecological nature of the study did not provide for studying the cause and effect
relationship. This is an area that l recommend for further study as it would complete the
knowledge this study has highlighted and provide policy makers and implementers knowledge to
use for policy, investments and implementation.
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Implications for Positive Social Change
While immunizations are one of the most successful public health interventions,
unfortunately access to immunizations in sub-Saharan Africa remains a challenge. Immunization
rates are below the global goals, pausing a challenge for increased morbidity and mortality to
vaccine preventable diseases. Immunizations are managed and administered in health systems
and the success is dependent on how strong and effective the health system is. Understanding the
predictors to access would contribute to increasing access to immunizations and benefits that
come with this.
This study took the systems approach by looking at the health systems building blocks
and examining them as predictors of access to immunizations. Understanding building blocks
and key variables that would help program managers with program and policy development. This
study did show a strong association between quality of service delivery, governance to access to
immunization, human resources and some socioeconomic factors.
This study highlights the importance and relevance of governance, service delivery,
human resources and socioeconomic factors in increasing access to immunization towards
achieving national but global goals. It highlights how important it is to understand the predictors
and how they work in a system to affect immunization access. It shows how important it is to
look at all the health systems blocks and invest in them to maximize the value of health systems
towards access to immunizations.
Having Micro Yearly Pans (MYP) that are comprehensive and using them as planning
and management tools that include finance, supply chain functions, staffing and ensuring steady
vaccines flow, no stockouts, looking at both the supply and demand side of immunizations would
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lead to a positive change. This study will contribute to national governments planning and
focusing on how best to plan for immunizations through the year, increasing and investing in
health systems blocks that might make a huge difference. This includes focusing on governance,
service delivery, human resources, planning, setting of targets and strengthening selection,
forecasting, procurement distribution functions of their supply chain to increase stock levels of
vaccines and avoid stockouts.
The study also shows the need to look at those determinants that did not show a strong
association and the reasons behind those results that would be informative in the immunization
agenda.
The results of this study will be disseminated by sharing with the Ministries of Health in
the nine countries, through conferences, workshops and publications in both peer reviewed
journals and open access journals.
Implications for Practice
The success of public health programs depend on good planning driven by data. This
includes immunization programs. This study has highlighted 4 main areas that can lead to
improved access to immunizations in sub-Saharan African countries and other LMICs. Firstly,
the importance of strong governance that invests in planning, having a comprehensive MYPs,
that can be used as a management too and strategy to increase access to immunizations including
through action plans informed by evidence (Petu, 2018). This should take into consideration the
unique and peculiar characteristics of the country and its regions. It should also contain
indicators, resources such as financial and human and targets.
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The second is the importance of taking the systems approach in improving access to
immunizations by looking at the health systems building blocks and understanding how they
influence and contribute the desired goal of the system, increased service delivery and access to
immunization by working in unison as a unit. Each health system building block has its
predictors some of which affect more than one health systems building blocks. By looking at
each building block and how it influences other building blocks is a critical element in
maximizing each buildings blocks contribution. Such an approach would address the inherent
challenges to immunizations such as human resources, sustainable funding, servive delivery
vaccine stockouts and supply chain functions such as logistics (Mihigo, Okeibunor, Anya,
Mkanda & Zawaira, 2017).
The third area is that of financing, ensuing vaccines are available and immunization
supplies on the supply side. This is one of the major challenges for most sub-Saharan African
countries, that requires these governments to increase funding especially with the competition
with donor funding and as most will be graduating from GAVI support for vaccine support and
immunization (Mihigo, Okeibunor, Anya, Mkanda & Zawaira, 2017).
Strengthening functions of the supply chain to increase vaccine supply is critical to
improving access. Availability, accessibility and affordability are critical elements. Fourthly the
key role and need for trained human doctors and health workers as essential to improving access.
Trained health care workers provide many functions that include information dissemination,
service delivery and manage EPI programs. Investing in health systems building blocks would
lead to increased access in countries.
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Public health planners need to take this into consideration and countries. Countries can
use findings from this study when making proposals for funding for immunizations to partners
and foreign agencies. Funders can also use this evidence to justify why they should fund
immunization programs and contribute to access to vaccines especially the newer vaccines that
are generally expensive.
Conclusion
Immunizations are effective in preventing many vaccine preventable infectious diseases.
They are a major success in public health and a cornerstone to universal health coverage.
Unfortunately access to immunizations remains a major problem in most sub-Saharan African
countries. The study is the first to use the systems approach in looking at the association of
health systems building blocks to access to immunization. The study supports the hypothesis that
health systems building blocks are predictors of access to immunizations. Health systems
building blocks, governance, service delivery, human resources and socioeconomic factors are
predictors of access to immunizations in sub-Saharan African countries.
The new knowledge derived in this study will be useful for country immunization
program planners, for policy makers to develop and implement evidence-based policies targeted
at increasing immunization. Strengthening governance and service delivery in the context of the
health system will be important. The results are also useful for funders in making decisions
concerning funding immunization programs by supporting investments and strengthening of
certain building blocks that have stronger association to immunizations.
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